UNCLASSIFIED
DATE
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2 Exhibit)
BUDGET ACTIVITY
February 2002
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
COST (In Thousands)
Total Program Element (PE) Cost
0603884BP CHEMICAL/BIOLOGICAL DEFENSE (DEMVAL)
FY 2001
FY 2002
FY 2003
FY 2004
FY 2005
FY 2006
FY 2007
Cost to
Actual
Estimate
Estimate
Estimate
Estimate
Estimate
Estimate
Complete
82315
89756
144790
100512
66662
45394
Total Cost
43976 Continuing Continuing
BJ4
BIOLOGICAL DEFENSE (DEMVAL)
5765
1560
3661
19163
19329
0
0
0
49478
CA4
CONTAMINATION AVOIDANCE (DEMVAL)
8866
16274
16963
0
0
0
0
0
42103
CO4
COLLECTIVE PROTECTION (DEMVAL)
1454
0
4390
0
0
0
0
0
5844
CP4
COUNTERPROLIFERATION SUPPORT (DEMVAL)
15709
15243
13423
20442
21137
24459
25516 Continuing Continuing
DE4
DECONTAMINATION SYSTEMS (DEMVAL)
3368
6143
6972
12378
14220
3997
3992 Continuing Continuing
HS4
HOMELAND SECURITY (DEMVAL)
0
0
55000
0
0
0
0
0
55000
IP4
INDIVIDUAL PROTECTION (DEMVAL)
16610
14317
0
0
0
0
0
0
30927
MB4
MEDICAL BIOLOGICAL DEFENSE (DEMVAL)
28465
34343
42617
46775
10271
14874
12361 Continuing Continuing
MC4
MEDICAL CHEMICAL DEFENSE (DEMVAL)
2078
1876
1764
1754
1705
2064
2107 Continuing Continuing
A. Mission Description and Budget Item Justification: Operational forces have an immediate need to survive, safely operate, and sustain
operations in a chemical and biological (CB) agent threat environment across the continuum of global, contingency, special operations/low
intensity conflict, counternarcotics, and other high risk missions. This program element supports the System Development and Demonstration
(SDD) of CB defensive equipment, both medical and non-medical. DoD missions for Homeland Security and for civil support operations have
recently expanded and have resulted in providing focus to develop technologies to support CB counterterrorism initiatives.
Page 1 of 112 Pages
UNCLASSIFIED
Exhibit R-2 (PE 0603884BP)
UNCLASSIFIED
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2 Exhibit)
BUDGET ACTIVITY
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
DATE
February 2002
PE NUMBER AND TITLE
0603884BP CHEMICAL/BIOLOGICAL DEFENSE (DEMVAL)
These projects have been structured to consolidate Joint and Service-unique tasks within four commodity areas: contamination avoidance, force
protection (individual and collective), decontamination, and medical countermeasures. This program is enhanced using Counterproliferation
Support Program funding. SDD is conducted for: an array of chemical/biological/toxin detection and warning systems to include ARTEMIS,
(formerly known as the Artemis Joint Service Warning and Identification Light Detection and Ranging (LIDAR) Detector (formerly known as
JSWILD)); decontamination capabilities to include the sorbent technology, the Joint Service Fixed Site Decontamination (JSFXD) and the Joint
Service Sensitive Equipment Decontamination (JSSED) programs. System development and demonstration is also conducted for the transition of
biological detection components (major thrusts include: (1) early warning; (2) collector concentrators; (3) generic detection; and (4) improved
reagents) for the future Joint Biological Point Detection System (JBPDS) Block II, Joint Biological Standoff Detection System, (JBSDS) and
Joint Biological Tactical Detection System (JBTDS).
In the medical chemical/biological defense area, SDD is conducted for improved medical equipment, vaccines, and drugs essential to
counteracting lethal and human performance degrading effects of chemical and biological agent threats. Specific items include improvements to
nerve agent antidotes, topical skin protectants, anticonvulsants, biological agent diagnostics, and vaccines to protect against various Biological
Warfare (BW) agents.
The Homeland Security System Development and Demonstration program is focused on supporting a dual use operational capability for
integrated biological-surveillance, detection, and alerting in the National Capital Region (NCR) with technology insertions for improved
performance and response.
This Program Element focuses on efforts associated with advanced technology development used to demonstrate general military utility to include
SDD in the area of chemical/biological defense equipment and is correctly placed in Budget Activity 4.
Page 2 of 112 Pages
UNCLASSIFIED
Exhibit R-2 (PE 0603884BP)
UNCLASSIFIED
DATE
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2 Exhibit)
BUDGET ACTIVITY
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
February 2002
PE NUMBER AND TITLE
0603884BP CHEMICAL/BIOLOGICAL DEFENSE (DEMVAL)
B. Program Change Summary:
FY 2001
FY 2002
FY 2003
Previous President's Budget (FY 2002 PB)
84992
82636
68042
Appropriated Value
89800
90336
0
0
0
0
-627
-580
0
-1438
0
0
0
0
0
-5236
0
0
-184
0
0
0
0
76748
82315
89756
144790
Adjustments to Appropriated Value
a. Congressional General Reductions
b. SBIR/STTR
c. Omnibus or Other Above Threshold Reductions
d. Below Threshold Reprogramming
e. Rescissions
Adjustments to Budget Years Since FY 2002 PB
Current Budget Submission (FY 2003 PB)
Change Summary Explanation:
Funding:
FY03 - Increase to the development program to fund a Homeland Security Support effort identified in the new Project
HS4 (+$55,000K); realignment of the JBPDS Block II program ($3,000K) in project BJ4; vaccine programs realigned
into Budget Activity 4 (MB4) from Budget Activity 5 (MB5) and production (+$10,801K); realignment of the CBDP
program to support ARTEMIS and Joint Effects Model (+$8,376K); adjustment for inflation assumptions (-$429K).
Schedule:
Technical:
C. Other Program Funding Summary: See section B in the R2A's
Page 3 of 112 Pages
UNCLASSIFIED
Exhibit R-2 (PE 0603884BP)
UNCLASSIFIED
DATE
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2A Exhibit)
BUDGET ACTIVITY
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
COST (In Thousands)
BJ4
February 2002
BIOLOGICAL DEFENSE (DEMVAL)
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
BJ4
FY 2001
FY 2002
FY 2003
FY 2004
FY 2005
FY 2006
FY 2007
Cost to
Actual
Estimate
Estimate
Estimate
Estimate
Estimate
Estimate
Complete
5765
1560
3661
19163
19329
0
0
Total Cost
0
49478
A. Mission Description and Budget Item Justification:
Project BJ4 BIOLOGICAL DEFENSE (DEMVAL): The Department of Defense (DoD) Biological Defense mission area requires the
detection and identification of biological threat agents to provide early warning capabilities at high value mobile and fixed site locations.
Collection, detection, and identification of biological warfare (BW) agents are among the highest Commander in Chief/Joint Requirements
Oversight Council (CINC/JROC) Counterproliferation priorities. Next generation biological detection systems will provide detection,
identification, warning, and sample collection for verification of large area and/or point source biological attacks. This project supports the
Technology Transition (TT) Bio program and Joint Biological Point Detection System (JBPDS) Blk II. The TT Bio program initiates the system
development and integration of lightweight early warning candidates for the Joint Biological Standoff Detection System (JBSDS) program.
FY 2001 Accomplishments:
2098 JBPDS Block II - Initiated modeling, design, fabrication, and test of next generation Biological Aerosol Warning
System (BAWS) prototype (one prototype at $150K).
·
·
·
Project BJ4
2461 TT Bio - Initiated system development and integration of a lightweight early warning system candidate for the Joint
Biological Standoff Detection System (JBSDS).
846 TT Bio - Continued development of critical reagents for fielded biological detection systems.
Page 4 of 112 Pages
UNCLASSIFIED
Exhibit R-2 (PE 0603884BP)
UNCLASSIFIED
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2A Exhibit)
BUDGET ACTIVITY
DATE
February 2002
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
BJ4
FY 2001 Accomplishments (Cont):
360 TT Bio - Initiated development of a lightweight short range biological detection system as a candidate for the Joint
Biological Standoff Detection System (JBSDS).
·
Total
5765
FY 2002 Planned Program:
990 TT Bio - Continue system development and integration of the lightweight, early warning, JBSDS system.
·
·
·
Total
544 TT Bio - Initiate testing of the integrated, lightweight, early warning JBSDS system.
26 SBIR - Small Business Innovative Research.
1560
FY 2003 Planned Program:
1603 JBPDS Block II - Develop software and hardware advances to BAWS algorithms that will provide increased reliability
and enhance the JBPDS Block II ability to discriminate background environment aerosol components, without
sacrificing sensitivity and responsiveness to biological warfare attacks.
·
·
·
Total
Project BJ4
1382 JBPDS Block II - Establish core and Joint service IPTs and initiate product improvements of Line Replaceable Units
(LRUs), through design, procurement, fabrication, and critical item testing.
676 TT Bio - Initiate the system development of enhanced environmental and military hardening packages for lightweight
early warning JBSDS candidate systems.
3661
Page 5 of 112 Pages
UNCLASSIFIED
Exhibit R-2 (PE 0603884BP)
UNCLASSIFIED
DATE
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2A Exhibit)
BUDGET ACTIVITY
February 2002
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
BJ4
B. Other Program Funding Summary:
FY 2001
FY 2002
FY 2003
FY 2004
FY 2005
FY 2006
FY 2007
To
Compl
Total
Cost
7575
12803
14660
17977
17315
37632
35708
Cont
Cont
CP4 COUNTERPROLIFERATION SUPPORT
(DEMVAL)
15709
15243
13423
20442
21137
24459
25516
Cont
Cont
JP0100 JOINT BIO POINT DETECTION SYSTEM
(JBPDS)
27260
36324
67528
75245
73514
56735
50879
Cont
Cont
JPO210 CRITICAL REAGENTS PROGRAM (CRP)
4284
1913
2010
1850
1894
2251
2301
Cont
Cont
BJ5 BIOLOGICAL DEFENSE (EMD)
Project BJ4
Page 6 of 112 Pages
UNCLASSIFIED
Exhibit R-2 (PE 0603884BP)
UNCLASSIFIED
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2A Exhibit)
BUDGET ACTIVITY
DATE
February 2002
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
BJ4
C. Acquisition Strategy:
TT Bio
This program initiates the system development and integration of modified commercial off the shelf (COTS) technologies
as JBSDS candidate systems. The program focuses on the rapid development, testing, and fielding of leading systems to
meet urgent warfighter needs for early warning of Biological Warfare (BW) agent attacks.
JBPDS Block II
A spiral development effort, initiated with a government run concept analysis in FY00, MS B/Development Contract
Award, FY04, and MS C, Low Rate Initial Production in FY07, and Full Rate Production in FY08. A concept analysis
consisting of modeling and simulation results will be given to one or more contractors for brassboard development and
testing. A preferred design will be carried through System Development by a prime systems contractor. Throughout
System Development, the program will advance biological point detection capabilities (smaller, lighter, lower power, dry
detection technologies, etc.) for operational level systems, and spiral incremental improvements into the Block I
production program as they become available.
Project BJ4
Page 7 of 112 Pages
UNCLASSIFIED
Exhibit R-2 (PE 0603884BP)
UNCLASSIFIED
DATE
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2A Exhibit)
BUDGET ACTIVITY
February 2002
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
D. Schedule Profile:
FY 2000
1
2
3
4
FY 2001
1
2
3
4
FY 2002
1
2
3
4
FY 2003
1
2
3
4
FY 2004
1
2
3
4
FY 2005
1
2
3
4
BJ4
FY 2006
1
2
3
4
FY 2007
1
2
3
JBPDSBLK2
Concept Development/Hardware
Exploration Phase I
1Q
4Q
Initial Overarching Integrated Process
Team (IT) Convened: February 18, 1999
Analysis of Alternatives/Concept Studies
1Q 2Q
1Q
1Q
Solicitation for EMD Contract
1Q 2Q
Milestone B
1Q
JBSDS
Component Advanced Development
1Q
2Q
TT Bio
Transition Lightweight, Environmentally
Enhanced, and Hardened JBSDS
Components into SD & D
Project BJ4
1Q
Page 8 of 112 Pages
UNCLASSIFIED
Exhibit R-2 (PE 0603884BP)
4
UNCLASSIFIED
DATE
CBDP PROJECT COST ANALYSIS (R-3 Exhibit)
BUDGET ACTIVITY
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
I. Product Development
February 2002
Contract
Method &
Type
Performing Activity &
Location
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
US
NF
CC
Total
PYs
Cost
FY2001
Cost
FY2001
Award
Date
FY2002
Cost
FY2002
Award
Date
FY2003
Cost
FY2003
Award
Date
BJ4
Cost to
Complete
Total
Cost
Target
Value of
Contract
JBPDSBLK2
BAWS Detector Algorithm
Improvement Studies
MIPR
Hanscom AFB/MITLexington, MA
F
0
0
NONE
0
NONE
100 1Q FY03
2673
2773
0
Adv LRUs and Breadboard
MIPR
Hanscom AFB/MITLexington, MA
F
0
0
NONE
0
NONE
1162 1Q FY03
0
1162
0
HW S - Design Advanced
Prototype BAWS
MIPR
Hanscom AFB/MITLexington, MA
F
0
1238 1Q FY01
0
NONE
517 1Q FY03
1932
3687
0
C
0
2461
Jan-01
1410
Jan-02
500
Jan-03
0
4371
0
TT Bio
HW S - TT Bio JBSDS LIDAR
C/CPFF Science and Engineering
Services, Inc.,
Burtonsville, MD
HW C - TT Bio
MIPR
USAMRIID, Ft. Detrick,
MD
U
469
246
Jan-01
0
NONE
0
NONE
0
715
0
SW SB - TT Bio
MIPR
NMRI, Bethesda, MD
U
214
200
Jan-01
0
NONE
0
NONE
0
414
0
HW C - TT Bio
MIPR
SBCCOM, Edgewood,
MD
U
0
100
Jan-01
0
NONE
0
NONE
0
100
0
HW C - TT Bio
MIPR
Dugway Proving Ground, U
UT
150
150
Jan-01
0
NONE
0
NONE
0
300
0
0
360
Aug-01
0
NONE
0
NONE
0
360
0
833
4755
4605
13882
HW S - TT Bio Modified Short
Range Biological Standoff
Detection System
C/CPFF Fibertek Inc., Herndon,
VA
Subtotal I. Product Development:
1410
2279
Remarks: HW S - FY01 - 1 prototype at $150K
Project BJ4
Page 9 of 112 Pages
UNCLASSIFIED
Exhibit R-3 (PE 0603884BP)
UNCLASSIFIED
DATE
CBDP PROJECT COST ANALYSIS (R-3 Exhibit)
BUDGET ACTIVITY
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
II. Support Costs
JBPDSBLK2
ES S - BAWS Integration
February 2002
Contract
Method &
Type
Performing Activity &
Location
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
US
NF
CC
Total
PYs
Cost
FY2001
Cost
FY2001
Award
Date
MIPR
Hanscom AFB/MITLexington, MA
F
0
Engineering Support
MIPR
Various
U
0
0
RFP Development and Evaluation
MIPR
Various
U
0
0
0
498
Subtotal II. Support Costs:
FY2002
Cost
498 1Q FY01
FY2002
Award
Date
0
NONE
NONE
0
NONE
NONE
0
NONE
0
FY2003
Cost
FY2003
Award
Date
0
BJ4
Cost to
Complete
NONE
Total
Cost
Target
Value of
Contract
0
498
0
308 1Q FY03
3578
3886
0
426 1Q FY03
691
1117
0
4269
5501
734
Remarks:
III. Test and Evaluation
JBPDSBLK2
Early Test and Evaluation of
Design
OTE SB - Early Operational
Assessment for Block II
Subtotal III. Test and Evaluation:
Contract
Method &
Type
PO
MIPR
Performing Activity &
Location
US
NF
CC
Total
PYs
Cost
FY2001
Cost
SBCCOM, APG, MD
U
0
Various
U
0
0
FY2001
Award
Date
0
NONE
FY2002
Cost
FY2002
Award
Date
0
NONE
362 1Q FY01
0
NONE
362
0
FY2003
Cost
FY2003
Award
Date
332 1Q FY03
0
332
NONE
Cost to
Complete
Total
Cost
Target
Value of
Contract
1435
1767
0
1649
2011
0
3084
3778
Remarks:
Project BJ4
Page 10 of 112 Pages
UNCLASSIFIED
Exhibit R-3 (PE 0603884BP)
UNCLASSIFIED
DATE
CBDP PROJECT COST ANALYSIS (R-3 Exhibit)
BUDGET ACTIVITY
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
IV. Management Services
JBPDSBLK2
HW C - Design Advanced
Bio-Suite Hardware
TT Bio
PM/MS S - TT Bio
ZSBIR
SBIR/STTR - Aggregated from
ZSBIR-SBIR/STTR
Subtotal IV. Management
Services:
February 2002
Contract
Method &
Type
MIPR
Performing Activity &
Location
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
US
NF
CC
Total
PYs
Cost
FY2001
Cost
FY2001
Award
Date
FY2002
Cost
FY2002
Award
Date
FY2003
Cost
FY2003
Award
Date
Various
U
0
0
NONE
0
NONE
140 1Q FY03
Various
JPO-BD, Falls Church,
VA
U
51
150
Oct-00
124
Oct-01
176
PO
HQ AMC, Alexandria,
VA
U
0
0
NONE
0
51
150
150
884
5765
1560
26 2Q FY02
BJ4
Cost to
Complete
Total
Cost
Target
Value of
Contract
2479
2619
0
Oct-02
0
501
0
NONE
0
26
0
316
2479
3146
3661
14437
26307
Remarks:
TOTAL PROJECT COST:
Project BJ4
Page 11 of 112 Pages
UNCLASSIFIED
Exhibit R-3 (PE 0603884BP)
UNCLASSIFIED
DATE
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2A Exhibit)
BUDGET ACTIVITY
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
COST (In Thousands)
CA4
CONTAMINATION AVOIDANCE (DEMVAL)
Project CA4
February 2002
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
CA4
FY 2001
FY 2002
FY 2003
FY 2004
FY 2005
FY 2006
FY 2007
Cost to
Actual
Estimate
Estimate
Estimate
Estimate
Estimate
Estimate
Complete
8866
16274
Page 12 of 112 Pages
UNCLASSIFIED
16963
0
0
0
0
Total Cost
0
Exhibit R-2 (PE 0603884BP)
42103
UNCLASSIFIED
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2A Exhibit)
BUDGET ACTIVITY
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
DATE
February 2002
PE NUMBER AND TITLE
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
CA4
A. Mission Description and Budget Item Justification:
Project CA4 CONTAMINATION AVOIDANCE (DEMVAL): This DEMVAL funding supports Component Advanced Development and
System Integration (CAD/SI) of reconnaissance, detection, and identification equipment. Items of equipment in this project are: (1) Nuclear,
Biological and Chemical Reconnaissance System (NBCRS) Fox Training System, (2) Artemis (formerly known as JSWILD), (3) the Chemical
Biological Mass Spectrometer (CBMS), (4) the Joint Effects Model (JEM), and the Mobile Chemical Agent Detector (MCAD). The NBCRS
Fox Training System will operate on virtual terrain and simulate Nuclear, Biological and Chemical threat to allow integrated training of NBCRS
Fox crews. Artemis will be a near-real time, modular, on-the-move, standoff Chemical Warfare (CW) agent detection and identification
capability, with 360-degree coverage, from a variety of platforms, at ranges on the order of 20 kilometers (km) or more. Fiscal Year (FY) 2001
is addressed within item CP4 - Counterproliferation Support (DEMVAL). The CBMS is a detector capable of both biological and chemical agent
detection and identification. The CBMS Block I system is a component of the P3I Biological Integrated Detection System (BIDS). The CBMS
Block II system is an improved system that is being developed for inclusion in the NBCRS Block II system (IAV-NBCRV) and the Joint Service
Lightweight NBCRS system. The CBMS II is being further enhanced to allow operation as a stand-alone system. JEM will be a
general-purpose, accredited model for predicting NBC hazards associated with the release of contaminants into the environment. JEM will be
developed in blocks and will be capable of modeling hazards in a variety of scenarios including: counterforce, passive defense, accident and/or
incidents (Block I), high altitude releases, urban NBC environments (Block II) and building interiors, and human performance degradation (Block
III). The MCAD is a commercially available remote sensing chemical vapor detector being evaluated in FY02 for possible applications in urban
or military situations.
Project CA4
Page 13 of 112 Pages
UNCLASSIFIED
Exhibit R-2 (PE 0603884BP)
UNCLASSIFIED
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2A Exhibit)
BUDGET ACTIVITY
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
DATE
February 2002
PE NUMBER AND TITLE
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
CA4
FY 2001 Accomplishments:
1502 ARTEMIS - Completed Analysis of Alternatives (AoA) (including modeling and simulation) to validate technology
alternatives. Completed independent Total Ownership Cost (TOC) analysis.
·
·
458 ARTEMIS - Supported initiation of the Joint Service Integration Group (JSIG) Contamination Avoidance (CA) Mission
Needs Analysis (MNA).
·
888 ARTEMIS - Initiated program acquisition strategy and documentation. Joint AoA Integrated Product Team (IPT)
provided support, oversight and coordination of AoA.
·
·
·
·
Total
Project CA4
1923 CBMS - Initiated design and planning to update CBMS Block II for fixed site and stand-alone applications.
250 JEM - Initiated IPT to evaluate hazard prediction technologies. Initiated program planning.
3745 NBCRS Blk I Fox (Training System) - Developed two NBCRS Fox Training Systems for installation at Fort Polk, LA
($1.8M each).
100 NBCRS Blk I Fox (Training System) - Tested NBCRS Fox Training Systems. Testing included software validation,
technical tests on all system components, a Limited User Test, and a maintenance evaluation. Trainers were designed
and tested uniquely for each facility installation.
8866
Page 14 of 112 Pages
UNCLASSIFIED
Exhibit R-2 (PE 0603884BP)
UNCLASSIFIED
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2A Exhibit)
BUDGET ACTIVITY
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
DATE
February 2002
PE NUMBER AND TITLE
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
CA4
FY 2002 Planned Program:
1274 ARTEMIS - Prepare source documentation for Milestone (MS) B. Maintain document library and information network
for all data, research, and other program information. Issue draft Request for Proposal (RFP) for System Development
and Demonstration (SDD) prototypes. Perform financial management, scheduling, planning, and reporting.
·
·
990 ARTEMIS - Develop initial systems architecture and draft systems specification through a Joint Systems Engineering
Integrated Product Team (IPT). Conduct risk analyses and develop risk mitigation plan.
·
446 ARTEMIS - Conduct, as an integral part of the systems engineering process, a supportability analysis. Conduct initial
Joint Training Planning Process Methodology and develop initial Joint System Training Plan. Develop acquisition
logistics support plan for MS B through a Joint Product Support IPT.
·
1351 ARTEMIS - Establish test strategy and develop test methodology. Develop initial Test & Evaluation Master Plan
(TEMP) through a Joint Test & Evaluation IPT.
·
3665 ARTEMIS - Continue development of key components of an active emitter multi-wave Light Detecting and Ranging
(LIDAR) technology to develop a system architecture and to reduce overall programmatic risk by utilizing Component
Advanced Development (CAD). Key components considered high risk are solid state lasers, non-consumable detectors,
and advanced detection algorithms. Demonstrate and validate performance of these components.
·
750 ARTEMIS - Support Systems Engineering IPT through Simulation Based Acquisition (SBA) activities to reduce cost,
schedule, and performance risks; increase the quality, military worth, and supportability of fielded systems; and reduce
total ownership costs throughout the system life cycle.
·
·
250 MCAD - Conduct initial agent and interference trials.
Project CA4
1750 MCAD - Conduct interference and operational trials in an urban environment.
Page 15 of 112 Pages
UNCLASSIFIED
Exhibit R-2 (PE 0603884BP)
UNCLASSIFIED
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2A Exhibit)
BUDGET ACTIVITY
DATE
February 2002
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
CA4
FY 2002 Planned Program (Cont):
4154 MCAD - Evaluate capability of MCAD to meet operational requirements of all Services and emerging National Defense
requirements for remote detection of chemical agents and other hazardous materials. NOTE: Defense Emergency
Response Fund (DERF) Enhanced Force Protection - $1018K received to be utilized in support of MCAD purchase,
testing, and evaluation in the National Capital Region (NCR).
·
·
1368 NBCRS Blk I Fox (Training System) - Initiated planning and equipment design for two Fox Training Systems for U.S.
Forces Korea (USFK).
·
Total
276 SBIR - Small Business Innovative Research.
16274
Project CA4
Page 16 of 112 Pages
UNCLASSIFIED
Exhibit R-2 (PE 0603884BP)
UNCLASSIFIED
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2A Exhibit)
BUDGET ACTIVITY
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
DATE
February 2002
PE NUMBER AND TITLE
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
CA4
FY 2003 Planned Program:
2679 ARTEMIS - Complete source documentation for MS B. Finalize and issue RFP, conduct source selection, award
contract for System Development and Demonstration (SDD) prototypes. Conduct Integrated Baseline Review (IBR)
and System Requirement Review (SRR) with SDD contractor.
·
·
·
4555 ARTEMIS - Initiate design, build, and integrate SDD prototypes for use in developmental testing.
·
2255 ARTEMIS - Develop detailed test support plan. Purchase additional test equipment to support range and chamber
testing of a long range active LIDAR standoff detection system.
·
1640 JEM Block I - Complete transition from tech base. Integrate counterforce, passive defense, and hazard/incident
software models into a complete system. Develop logistics documentation, initiate Post Deployment Software Support
planning, and establish online document library and information network for all data, research, and other program
information. Update MS B program documentation and conduct MS B decision. Conduct source selection for
development of a standardized hazard prediction model. Perform financial management, scheduling, planning, and
reporting.
Project CA4
2000 ARTEMIS - Initiate design, documentation, development of Artemis system software. In addition, initiate effort to
develop interface between Artemis and Joint Warning and Reporting Network (JWARN).
Page 17 of 112 Pages
UNCLASSIFIED
Exhibit R-2 (PE 0603884BP)
UNCLASSIFIED
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2A Exhibit)
BUDGET ACTIVITY
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
DATE
February 2002
PE NUMBER AND TITLE
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
CA4
FY 2003 Planned Program (Cont):
819 JEM Block I - Develop Test and Evaluation Master Plan (TEMP) and Verification, Validation, and Accreditation Plan.
Complete analysis of existing field test data associated with the hazard prediction models Vapor, Liquid and Solid
Tracking (VLSTRACK), Hazard Prediction and Assessment Capability (HPAC), and Personal Computing Program for
the Chemical Hazard Prediction (D2PC) and identify data gaps. Prepare for and conduct Early Operational Assessment
(EOA). Initiate Independent Validation and Verification (IV&V) effort. Develop and refine warfighter use cases.
Perform engineering analysis and evaluation of software design documentation. Establish and conduct Change Control
Board. Continue technical data transition of HPAC, VLSTRACK, and D2PC models.
·
·
Total
3015 JEM Block I - Award contract for development of engineering builds (software only) in support of the Block I effort.
16963
Project CA4
Page 18 of 112 Pages
UNCLASSIFIED
Exhibit R-2 (PE 0603884BP)
UNCLASSIFIED
DATE
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2A Exhibit)
BUDGET ACTIVITY
February 2002
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
CA4
B. Other Program Funding Summary:
FY 2001
FY 2002
FY 2003
FY 2004
FY 2005
FY 2006
FY 2007
To
Compl
Total
Cost
59268
71421
58341
36689
18929
30581
13468
Cont
Cont
9018
0
0
0
12194
15956
31916
Cont
Cont
JA0001 ARTEMIS ACTIVE STANDOFF CW
DETECTION SYSTEM
0
0
0
0
0
0
7979
Cont
Cont
JCA208 JOINT EFFECTS MODEL
0
0
0
0
990
988
987
Cont
Cont
JF0100 JOINT CHEM AGENT DETECTOR (JCAD)
0
0
6031
19411
20437
26991
30273
Cont
Cont
M98801 AUTO CHEMICAL AGENT ALARM
(ACADA), M22
68877
591
1035
0
0
0
0
0
70503
MA0601 RECON SYSTEM, FOX NBC (NBCRS)
MODS
57651
6312
16474
24295
25268
24931
997
Cont
Cont
0
0
28345
50623
66594
74019
81867
Cont
Cont
4696
4670
4673
0
0
0
0
0
14039
CA5 CONTAMINATION AVOIDANCE (EMD)
G47101 JOINT WARNING & REPORTING
NETWORK (JWARN)
MC0100 JT SVC LTWT NBC RECON SYS
(JSLNBCRS)
N00041 SHIPBOARD DETECTOR
MODIFICATIONS
Project CA4
Page 19 of 112 Pages
UNCLASSIFIED
Exhibit R-2 (PE 0603884BP)
UNCLASSIFIED
DATE
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2A Exhibit)
BUDGET ACTIVITY
February 2002
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
CA4
B. Other Program Funding Summary (Cont):
S10801 JS LTWT STANDOFF CW AGT DETECTOR
(JSLSCAD)
Project CA4
FY 2001
FY 2002
FY 2003
FY 2004
FY 2005
FY 2006
FY 2007
To
Compl
Total
Cost
0
10327
0
15386
23230
39891
44881
Cont
Cont
Page 20 of 112 Pages
UNCLASSIFIED
Exhibit R-2 (PE 0603884BP)
UNCLASSIFIED
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2A Exhibit)
BUDGET ACTIVITY
DATE
February 2002
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
CA4
C. Acquisition Strategy:
NBCRS BLK I
Fox (Training System) Task order to ITT Industries to develop, deliver, and install two NBCRS Fox Trainers to Fort
Hood, TX, and two NBCRS Fox Trainers to Fort Polk, LA. Trainers operate on virtual terrain and simulate Nuclear,
Biological, and Chemical threat to allow integrated training of NBCRS Fox crews. The FY02 task order will be awarded
to develop, deliver, and install two NBCRS Fox Trainers for U.S. Forces Korea (USFK).
ARTEMIS
Formerly known as JSWILD. The Artemis program will use an evolutionary acquisition (Block) approach for design,
development, testing, and fielding. Develop a system specification and issue a draft Request for Proposal (RFP) prior to
Milestone (MS) B to resolve industry comments. Award a cost-plus type contract after MS B, for engineering
development models in support of the System Development and Demonstration (SDD) phase. Conduct developmental
testing and early operational assessments of engineering development models to ensure compliance with the Operational
Requirements Document (ORD). After MS C, award a fixed-fee contract for Low Rate Initial Production (LRIP) units to
support Initial Operational Test & Evaluation (IOT&E). A Full Rate Production (FRP) option to this contract will be
exercised after the FRP Decision Review.
CBMS I
System Development and Demonstration (SDD) phase was developed under a task order contract with Bruker
Industries. The system was type-classified as part of the P3I BIDS system. The CBMS II was developed under an
interagency agreement with Oak Ridge National Lab, with Orbital Sciences Corp as the main subcontractor. The system
will be type classified as a component of the Fox Block II system (IAV-NBCRV) and the Joint Service Lightweight
NBCRS system. An effort is being initiated to configure the system as a stand-alone.
Project CA4
Page 21 of 112 Pages
UNCLASSIFIED
Exhibit R-2 (PE 0603884BP)
UNCLASSIFIED
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2A Exhibit)
BUDGET ACTIVITY
DATE
February 2002
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
CA4
JEM
The JEM program will use a three block evolutionary acquisition approach for the design, development, testing, and
fielding of JEM (Blocks I, II, and III). Upon completion of an Independent Model Analysis, JEM interface, credibility
and performance requirements will be refined in an iterative process through a series of design reviews, using
cost-effective graphical storyboarding prior to actual implementation of the algorithms and data harvested from the legacy
Nuclear, Biological, and Chemical (NBC) models. A cost plus award/incentive fee contract will be used for model
development.
MCAD
The MCAD evaluation will be conducted as a one-year effort. The program will utilize sole-source contracting and other
expedited acquisition procedures to permit an accurate and rapid determination of MCAD capability to fit emerging
National Defense and military requirements.
Project CA4
Page 22 of 112 Pages
UNCLASSIFIED
Exhibit R-2 (PE 0603884BP)
UNCLASSIFIED
DATE
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2A Exhibit)
BUDGET ACTIVITY
February 2002
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
D. Schedule Profile:
FY 2000
1
2
3
4
FY 2001
1
2
3
4
FY 2002
1
2
3
4
FY 2003
1
2
3
4
FY 2004
1
2
3
4
FY 2005
1
2
3
4
CA4
FY 2006
1
2
3
4
FY 2007
1
2
3
ARTEMIS
Concept Exploration
Analysis of Alternatives
>>
1Q
2Q
4Q
Milestone Component Advanced
Development (CAD)
1Q
Milestone C Low Rate Initial Production
(LRIP)
1Q
Component Advanced Development
1Q
BLK I - Release Draft Request for Proposal
(RFP)
4Q
3Q
BLK I - Milestone B Decision
1Q
BLK I - Release Request for Proposal
(RFP)
1Q
3Q
BLK I - Award Contract (Prototype)
3Q
BLK I - Prototype Hardware/Software
Development
3Q
3Q
BLK I - System Requirements Review
(SRR)
1Q
BLK I - Integrated Baseline Review (IBR)
1Q
Project CA4
Page 23 of 112 Pages
UNCLASSIFIED
Exhibit R-2 (PE 0603884BP)
4
UNCLASSIFIED
DATE
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2A Exhibit)
BUDGET ACTIVITY
February 2002
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
D. Schedule Profile (cont):
FY 2000
1
2
3
4
FY 2001
1
2
3
4
FY 2002
1
2
3
4
FY 2003
1
2
3
4
FY 2004
1
2
3
4
FY 2005
1
2
3
4
CA4
FY 2006
1
2
3
4
FY 2007
1
2
3
ARTEMIS (Cont)
BLK I - System Function Requirements
(SFR)
3Q
BLK I - Early Prototypes Delivered
3Q
BLK I - Prototype Developmental Testing
(DT I)
3Q 4Q
BLK I - Early Operational Assessment
1Q
BLK I - Advanced Prototypes Delivered
2Q
BLK I - Prototype Developmental Testing
(DT II)
2Q
BLK I - Operational Assessment (OA)
3Q
Developmental Test I (DT I) LAV variant
2Q
BLK I - Award Low Rate Initial Production
(LRIP) Contract / Option
2Q
CBMS
Block II - Engineering Tests
>>
3Q
JEM
BLK I Milestone A Decision
Project CA4
3Q
Page 24 of 112 Pages
UNCLASSIFIED
Exhibit R-2 (PE 0603884BP)
4
UNCLASSIFIED
DATE
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2A Exhibit)
BUDGET ACTIVITY
February 2002
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
D. Schedule Profile (cont):
FY 2000
1
2
3
4
FY 2001
1
2
3
4
FY 2002
1
2
3
4
FY 2003
1
2
3
4
FY 2004
1
2
3
4
FY 2005
1
2
3
4
CA4
FY 2006
1
2
3
4
FY 2007
1
2
3
JEM (Cont)
BLK I Independent Model Analysis
(CB3-TBNM)
1Q 2Q
Component Advanced Development (CAD)
Review (CB3-TBNM)
3Q
BLK I Storyboard Development
(CB3-TBNM)
3Q
Final Test Evaluation Master Plan (TEMP)
1Q
1Q
BLK I Milestone B Decision
2Q
BLK I Award System Development and
Demonstration (SDD) Contract
2Q
BLK I Software Development (Engineering
builds)
2Q
4Q
BLK I Early Operational Assessment
(EOA)
4Q
BLK I Software Development (Block I
Formal)
4Q
3Q
BLK I Developmental Testing
2Q
BLK I Operational Assessment (OA)
2Q
BLK I Milestone C Decision
Project CA4
3Q
Page 25 of 112 Pages
UNCLASSIFIED
Exhibit R-2 (PE 0603884BP)
4
UNCLASSIFIED
DATE
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2A Exhibit)
BUDGET ACTIVITY
February 2002
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
D. Schedule Profile (cont):
FY 2000
1
2
3
4
FY 2001
1
2
3
4
FY 2002
1
2
3
4
FY 2003
1
2
3
4
FY 2004
1
2
3
4
FY 2005
1
2
3
4
CA4
FY 2006
1
2
3
4
FY 2007
1
2
3
JEM (Cont)
BLK I Technical Evaluation (TECHEVAL)
4Q
BLK I Operational Testing (OT)
1Q
BLK I Initial Operational Capability (IOC)
2Q
MCAD
Conduct agent and interference trials
2Q 3Q
Conduct urban interference trials
3Q 4Q
NBCRSBLKI
Fox Trainer Hardware Fabrication and
Procurement, Fort Polk Systems
Fox Trainer Software Development, Fort
Polk Systems
Fox Trainer Installation at Fort Polk
Fox Trainer System Engineering Study
Operational Assessment 2 (OA II)
Project CA4
3Q
3Q
4Q
3Q
3Q
2Q 3Q
3Q
Page 26 of 112 Pages
UNCLASSIFIED
Exhibit R-2 (PE 0603884BP)
4
UNCLASSIFIED
DATE
CBDP PROJECT COST ANALYSIS (R-3 Exhibit)
BUDGET ACTIVITY
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
I. Product Development
ARTEMIS
HW S - Early Prototype Development
SW S - Early Prototype Development
SW SB - Multiwave LIDAR Component Advanced
Development Task
HW S - Early Prototype - System
Integration
HW SB - Multiwave LIDAR Component Advanced
Development Task
CBMS
HW S - CBMS - Initiate and
Upgrade CBMS Block II for Fixed
Site and Stand Alone Application
JEM
SW S - Engineering Builds Prototyping, Design and Code
SW GFPR - HPAC, VLSTRACK
& D2PC Source
Code/Development Environment SPAWARSYSCOM
Project CA4
February 2002
Contract
Method &
Type
Performing Activity &
Location
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
US
NF
CC
Total
PYs
Cost
FY2001
Cost
FY2001
Award
Date
FY2002
Cost
FY2002
Award
Date
FY2003
Cost
FY2003
Award
Date
CA4
Cost to
Complete
Total
Cost
Target
Value of
Contract
C/CPFF TBS
C
0
0
NONE
0
NONE
3480
Oct-02
2678
6158
6158
C/CPFF TBS
C
0
0
NONE
0
NONE
1500
Oct-02
1887
3387
3387
U
0
0
NONE
1235
Oct-01
0
NONE
0
1235
1235
C
0
0
NONE
0
NONE
500
Oct-02
2200
2700
2700
U
0
0
NONE
1930
Oct-01
0
NONE
0
1930
1930
C/CPFF Oak Ridge National Lab,
Oak Ridge, TN (OSC,
Pomona, CA - sub)
C
0
1226
Oct-01
0
NONE
0
NONE
0
1226
0
C/CPIF
TBS
C
0
0
NONE
0
NONE
3015
Jan-03
5000
8015
8015
Various
U
0
0
NONE
0
NONE
60
Oct-02
0
60
60
MIPR
SBCCOM, APG, MD
C/CPFF TBS
MIPR
MIPR
SBCCOM, APG, MD
Page 27 of 112 Pages
UNCLASSIFIED
Exhibit R-3 (PE 0603884BP)
UNCLASSIFIED
DATE
CBDP PROJECT COST ANALYSIS (R-3 Exhibit)
BUDGET ACTIVITY
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
I. Product Development - Cont.
February 2002
Contract
Method &
Type
Performing Activity &
Location
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
US
NF
CC
Total
PYs
Cost
FY2001
Cost
FY2001
Award
Date
FY2002
Cost
FY2002
Award
Date
FY2003
Cost
FY2003
Award
Date
CA4
Cost to
Complete
Total
Cost
Target
Value of
Contract
NBCRSBLKI
SW SB - Fabricate/Integrate
NBCRS Fox Training Systems
SS/CPFF ITT Industries,
Alexandria, VA
C
3138
3423
Mar-01
946
Mar-02
0
NONE
0
7507
0
SW SB - Install NBCRS Fox
Training Systems
C/CPFF ITT Industries,
Alexandria, VA
C
200
200
Mar-01
200
Mar-02
0
NONE
0
600
0
3338
4849
11765
32818
Subtotal I. Product Development:
4311
8555
Remarks: NBCRSBLKI - Training systems at Ft. Polk, LA. FY02 Training Systems planned for Korea.
Project CA4
Page 28 of 112 Pages
UNCLASSIFIED
Exhibit R-3 (PE 0603884BP)
UNCLASSIFIED
DATE
CBDP PROJECT COST ANALYSIS (R-3 Exhibit)
BUDGET ACTIVITY
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
II. Support Costs
February 2002
Contract
Method &
Type
Performing Activity &
Location
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
US
NF
CC
Total
PYs
Cost
FY2001
Cost
FY2001
Award
Date
FY2002
Cost
FY2002
Award
Date
FY2003
Cost
FY2003
Award
Date
CA4
Cost to
Complete
Total
Cost
Target
Value of
Contract
ARTEMIS
ES S - IPT - Joint Test and
Evaluation Plan
MIPR
Various
U
0
0
NONE
615
Oct-01
380
Oct-02
2400
3395
3395
ES S - IPT - Test Support
MIPR
DPG, Dugway, UT
U
0
0
NONE
350
Oct-01
100
Oct-02
950
1400
1400
N
0
0
NONE
300
Oct-01
125
Oct-02
395
820
820
ES S - IPT - Test Methodology
ILS S - IPT - Product Support
ILS S - IPT - Product Support
ES S - Early Prototype Simulation Support Plan
ES S - IPT - Systems Engineering
C/CPFF Battelle, Arlington, VA
MIPR
Various
C/CPFF Battelle, Arlington, VA
WR
0
NONE
188
Oct-01
157
Oct-02
1500
1845
1845
0
NONE
258
Oct-01
112
Oct-02
900
1270
1270
U
0
0
NONE
750
Oct-01
0
NONE
200
950
950
U
0
0
NONE
690
Oct-01
450
Oct-02
1688
2828
2828
C/CPFF Battelle, Arlington, VA
N
0
0
NONE
300
Oct-01
150
Oct-02
563
1013
1013
TD/D S - Early Prototype Drawings
C/CPFF TBS
C
0
0
NONE
0
NONE
150
Oct-02
450
600
600
ES S - IPT - Test Strategy
Development Support
C/CPFF Battelle, Arlington, VA
N
0
0
NONE
86
Oct-01
0
NONE
0
86
86
U
0
56
Aug-01
112
Oct-01
0
NONE
0
168
112
ES SB - Sample Identification Unit C/CPFF TBS
In-service Engineering
C
0
0
NONE
0
NONE
425
Oct-02
0
425
425
ES S - AoA - Report
N
0
1235
Dec-00
0
NONE
0
NONE
0
1235
0
U
0
267
Dec-00
0
NONE
0
NONE
0
267
0
N
0
402
Aug-01
0
NONE
0
NONE
0
402
0
ES S - IPT - AoA Oversight
ES S - MNA - Report
Project CA4
MIPR
Various
0
0
ES S - IPT - Systems Engineering
Support
ES S - MNA - Engineering
Support
MIPR
NSWCDD, Dahlgren,
VA
U
N
Various
C/CPFF Battelle, Arlington, VA
MIPR
Various
C/CPFF Battelle, Arlington, VA
Page 29 of 112 Pages
UNCLASSIFIED
Exhibit R-3 (PE 0603884BP)
UNCLASSIFIED
DATE
CBDP PROJECT COST ANALYSIS (R-3 Exhibit)
BUDGET ACTIVITY
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
II. Support Costs - Cont.
CBMS
ES S - CBMS - Contract
Engineering Support
JEM
ES S - IPT - Joint Test &
Evaluation Planning
February 2002
Contract
Method &
Type
Performing Activity &
Location
C/CPFF Oak Ridge National Lab,
Oak Ridge, TN (OSC,
Pomona, CA - sub)
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
US
NF
CC
Total
PYs
Cost
FY2001
Cost
FY2001
Award
Date
FY2002
Cost
FY2002
Award
Date
FY2003
Cost
FY2003
Award
Date
CA4
Cost to
Complete
Total
Cost
Target
Value of
Contract
C
0
293
Oct-01
0
NONE
0
NONE
0
293
0
MIPR
Various
U
0
0
NONE
0
NONE
578
Oct-02
3148
3726
3726
ES S - IPT - Warfighter Storyboard
Development
MIPR
Various
U
0
0
NONE
0
NONE
241
Oct-02
240
481
481
ES S - IPT - C4I/Data
Interoperability Planning
MIPR
Various
U
0
0
NONE
0
NONE
246
Oct-02
492
738
738
ILS S - IPT - Product Support
Planning
MIPR
Various
U
0
0
NONE
0
NONE
240
Oct-02
480
720
720
ES S - IPT - Prediction Model
Reuse Analysis
MIPR
Various
U
0
0
NONE
0
NONE
240
Oct-02
480
720
720
HQ AMC, Alexandria,
VA
U
0
0
NONE
0
NONE
640
Oct-02
900
1540
1540
0
2253
14786
24922
ES S - IPT - System Integration
Subtotal II. Support Costs:
WR
3649
4234
Remarks:
Project CA4
Page 30 of 112 Pages
UNCLASSIFIED
Exhibit R-3 (PE 0603884BP)
UNCLASSIFIED
DATE
CBDP PROJECT COST ANALYSIS (R-3 Exhibit)
BUDGET ACTIVITY
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
III. Test and Evaluation
ARTEMIS
OTHT SB - Multiwave LIDAR Demonstrate Component Advance
Development Tasks
DTE S - Early Prototype Purchase Additional Ground
Equipment
DTE S - Early Prototype Developmental Testing
CBMS
DTE S - CBMS - Conduct
Environmental Testing to Verify
Stand Alone Performance
MCAD
OTHT S - Agent and Interference
Trials
February 2002
Contract
Method &
Type
Performing Activity &
Location
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
US
NF
CC
Total
PYs
Cost
FY2001
Cost
FY2001
Award
Date
FY2002
Cost
FY2002
Award
Date
FY2003
Cost
FY2003
Award
Date
CA4
Cost to
Complete
Total
Cost
Target
Value of
Contract
MIPR
SBCCOM, APG, MD
U
0
0
NONE
500
Oct-01
0
NONE
0
500
500
MIPR
DPG, Dugway, UT
U
0
0
NONE
0
NONE
1650
Oct-02
0
1650
1650
C/CPFF TBS
C
0
0
NONE
0
NONE
500
Oct-02
1250
1750
1750
C/CPFF Oak Ridge National Lab,
Oak Ridge, TN (OSC,
Pomona, CA - sub)
C
0
250
Oct-00
0
NONE
0
NONE
0
250
0
SS/FP
Northrop/Grumann, VA
C
0
0
NONE
100 2Q FY02
0
NONE
0
100
0
OTHT S - Urban area operation
testing
MIPR
PM NBCDS, SBCCOM,
APG, MD
C
0
0
NONE
1750 3Q FY02
0
NONE
0
1750
0
OTHT S - Test Support
MIPR
PM NBCDS, SBCCOM,
APG, MD
U
0
0
NONE
150 2Q FY02
0
NONE
0
150
0
PO
PM NBCDS, SBCCOM,
APG, MD
U
0
0
NONE
4000 4Q FY02
0
NONE
0
4000
0
OTHT S - Interference and
capability testing in various
scenarios
Project CA4
Page 31 of 112 Pages
UNCLASSIFIED
Exhibit R-3 (PE 0603884BP)
UNCLASSIFIED
DATE
CBDP PROJECT COST ANALYSIS (R-3 Exhibit)
BUDGET ACTIVITY
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
III. Test and Evaluation - Cont.
NBCRSBLKI
TD/D C - Analysis to Integrate JS
Air/Ground Requirements and
Insert Block I Glove Data.
Subtotal III. Test and Evaluation:
February 2002
Contract
Method &
Type
Performing Activity &
Location
SS/CPFF ITT Industries,
Alexandria, VA
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
US
NF
CC
C
Total
PYs
Cost
FY2001
Cost
100
100
100
350
FY2001
Award
Date
Mar-01
FY2002
Cost
100
6600
FY2002
Award
Date
Mar-02
FY2003
Cost
FY2003
Award
Date
0
2150
NONE
CA4
Cost to
Complete
Total
Cost
Target
Value of
Contract
0
300
1250
10450
Remarks: NBCRSBLK1 (Training System) - Testing includes software validation, a Limited User Test, and a maintenance evaluation. Trainers are designed and tested uniquely for each
installation. This includes systems integration with the Close Combat Tactical Training Center.
Project CA4
Page 32 of 112 Pages
UNCLASSIFIED
Exhibit R-3 (PE 0603884BP)
200
UNCLASSIFIED
DATE
CBDP PROJECT COST ANALYSIS (R-3 Exhibit)
BUDGET ACTIVITY
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
IV. Management Services
ARTEMIS
PM/MS S - Program Office Planning & Programming
PM/MS S - Program Office Program Support
PM/MS S - IPT - Management
CBMS
PM/MS C - Program Management
JEM
PM/MS S - Program Office Planning & Programming
Contract
Method &
Type
WR
Performing Activity &
Location
NSWCDD, Dahlgren,
VA
Various
WR
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
US
NF
CC
Total
PYs
Cost
FY2001
Cost
FY2001
Award
Date
FY2002
Cost
FY2002
Award
Date
FY2003
Cost
FY2003
Award
Date
CA4
Cost to
Complete
Total
Cost
Target
Value of
Contract
0
618
Oct-00
583
Oct-01
793
Oct-02
7200
9194
8576
N
0
270
Oct-00
472
Oct-01
918
Oct-02
8100
9760
9545
Various
U
0
0
NONE
107
Oct-01
99
Oct-02
500
706
706
Oak Ridge National Lab,
Oak Ridge, TN (OSC,
Pomona, CA - sub)
U
0
154
Oct-00
0
NONE
0
NONE
0
154
0
SPAWARSYSCOM, San U
Diego, CA
0
150
Sep-01
0
NONE
214
Oct-02
480
844
720
0
50
Sep-01
0
NONE
0
NONE
0
50
0
0
50
Sep-01
0
NONE
0
NONE
0
50
0
C/CPFF Battelle, Arlington, VA
MIPR
PROJECT
U
PM/MS S - - Program Support
C/CPFF Battelle, Arlington, VA
PM/MS S - Program Support
C/CPFF SAIC, San Diego, CA
MCAD
PM/MS S - MCAD Evaluation
February 2002
N
MIPR
PM NBCDS, SBCCOM,
APG, MD
U
0
0
NONE
154 3Q FY02
0
NONE
0
154
0
NBCRSBLKI
PM/MS S - Conduct
Program/Project Management
PO
PM NBCDS, APG, MD
& Fort Monmouth, NJ
U
122
122
Oct-00
122
0
NONE
0
366
122
ZSBIR
SBIR/STTR - Aggregated from
ZSBIR-SBIR/STTR
PO
HQ AMC, Alexandria,
VA
U
0
0
NONE
276 2Q FY02
0
NONE
0
276
0
Project CA4
Page 33 of 112 Pages
UNCLASSIFIED
Oct-01
Exhibit R-3 (PE 0603884BP)
UNCLASSIFIED
DATE
CBDP PROJECT COST ANALYSIS (R-3 Exhibit)
BUDGET ACTIVITY
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
IV. Management Services - Cont.
Subtotal IV. Management
Services:
February 2002
Contract
Method &
Type
Performing Activity &
Location
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
US
NF
CC
Total
PYs
Cost
FY2001
Cost
FY2001
Award
Date
FY2002
Cost
FY2002
Award
Date
FY2003
Cost
FY2003
Award
Date
CA4
Cost to
Complete
Total
Cost
122
1414
1714
2024
16280
21554
3560
8866
16274
16963
44081
89744
Target
Value of
Contract
Remarks:
TOTAL PROJECT COST:
Project CA4
Page 34 of 112 Pages
UNCLASSIFIED
Exhibit R-3 (PE 0603884BP)
UNCLASSIFIED
DATE
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2A Exhibit)
BUDGET ACTIVITY
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
COST (In Thousands)
CO4
February 2002
COLLECTIVE PROTECTION (DEMVAL)
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
CO4
FY 2001
FY 2002
FY 2003
FY 2004
FY 2005
FY 2006
FY 2007
Cost to
Actual
Estimate
Estimate
Estimate
Estimate
Estimate
Estimate
Complete
1454
0
4390
0
0
0
0
Total Cost
0
5844
A. Mission Description and Budget Item Justification:
Project CO4 COLLECTIVE PROTECTION (DEMVAL): This DEMVAL funding supports Component Advanced Development and System
Integration (CAD/SI) of CB collective protection systems that are smaller, lighter, less costly and more easily supported logistically at the crew,
unit, ship, and aircraft level.
The Joint Transportable Collective Protection System (JTCOPS) will use the latest technologies to provide the next generation of lightweight,
modular, and self-supporting collective protection shelter systems. JTCOPS Block I will backfit selected existing standard military tent systems
with a collective protection capability beyond that which is currently available. JTCOPS Block II will fully integrate next-generation collective
protection into future military tent systems to provide NBC protection that is integral to the system.
FY 2001 Accomplishments:
1454 JTCOPS - Revised the acquisition strategy to a block approach to align the program with user priorities. Revised the
Milestone B documentation and the development contract request for proposals (RFP) for Block I.
·
Total
1454
FY 2002 Planned Program: No planned program
Project CO4
Page 35 of 112 Pages
UNCLASSIFIED
Exhibit R-2 (PE 0603884BP)
UNCLASSIFIED
DATE
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2A Exhibit)
BUDGET ACTIVITY
February 2002
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
CO4
FY 2003 Planned Program:
4390 JTCOPS - Conduct Milestone B Decision Review for Block I. Release a Request for Proposals, evaluate proposals and
award a development contract for Block I. Begin the design phase of the contract.
·
Total
4390
B. Other Program Funding Summary:
FY 2001
FY 2002
FY 2003
FY 2004
FY 2005
FY 2006
FY 2007
To
Compl
Total
Cost
CO5 COLLECTIVE PROTECTION (EMD)
3137
3987
4301
8122
6690
4239
4718
Cont
Cont
JN0017 JOINT COLLECTIVE PROTECTION
EQUIPMENT
1038
2378
1377
1927
2235
2095
1846
Cont
Cont
0
0
0
0
2020
1995
1995
Cont
Cont
JN0022 JT TRANSPORTABLE COLLECTIVE
PROTECTION SHELTER
C. Acquisition Strategy:
JTCOPS
Project CO4
Block I will develop a new collective protection capability for existing DoD shelters. A competitive contract will be
awarded for the design and prototype fabrication phase, with options for Low Rate Initial Production (LRIP) and
production. After successful completion of Development Testing and the Milestone C decision, the LRIP option will be
exercised to obtain prototypes for Operational Testing (OT). After completion of OT and the Full Rate Production
decision, the production option on the contract will be exercised. Block II is scheduled to begin in FY05.
Page 36 of 112 Pages
UNCLASSIFIED
Exhibit R-2 (PE 0603884BP)
UNCLASSIFIED
DATE
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2A Exhibit)
BUDGET ACTIVITY
February 2002
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
D. Schedule Profile:
FY 2000
1
2
3
4
FY 2001
1
2
3
4
FY 2002
1
2
3
4
FY 2003
1
2
3
4
FY 2004
1
2
3
4
FY 2005
1
2
3
4
CO4
FY 2006
1
2
3
4
FY 2007
1
2
3
JTCOPS
Conduct Planning Efforts for Milestone B
1Q
4Q
Milestone B - Block I
2Q
Design and Fabricate Prototypes for
Development Test (DT) - Block I
Project CO4
3Q
Page 37 of 112 Pages
UNCLASSIFIED
4Q
Exhibit R-2 (PE 0603884BP)
4
UNCLASSIFIED
DATE
CBDP PROJECT COST ANALYSIS (R-3 Exhibit)
BUDGET ACTIVITY
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
I. Product Development
Contract
Method &
Type
Performing Activity &
Location
JTCOPS
HW S - Block I System Design and C/CPFF TBS
Test Item Fabrication with Options
for LRIP and Production
Subtotal I. Product Development:
February 2002
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
US
NF
CC
C
Total
PYs
Cost
FY2001
Cost
FY2001
Award
Date
0
0
0
0
NONE
FY2002
Cost
FY2002
Award
Date
0
0
NONE
FY2003
Cost
FY2003
Award
Date
CO4
Cost to
Complete
Total
Cost
Target
Value of
Contract
3200 1Q FY03
0
3200
3200
0
3200
Remarks:
Project CO4
Page 38 of 112 Pages
UNCLASSIFIED
Exhibit R-3 (PE 0603884BP)
0
UNCLASSIFIED
DATE
CBDP PROJECT COST ANALYSIS (R-3 Exhibit)
BUDGET ACTIVITY
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
II. Support Costs
JTCOPS
ES S - Block I Proposal
Evaluations and Design Reviews
ILS S - Block I ILS Management
Activities
TD/D S - Block I Integrated
Logistic Support Data
February 2002
Contract
Method &
Type
Performing Activity &
Location
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
US
NF
CC
Total
PYs
Cost
FY2001
Cost
FY2001
Award
Date
MIPR
See remarks
U
0
MIPR
SBCCOM - Rock Island,
IL
U
0
C
0
0
0
40
C/CPFF TBS
Subtotal II. Support Costs:
PROJECT
0
NONE
40 1Q FY01
NONE
FY2002
Cost
FY2002
Award
Date
FY2003
Cost
FY2003
Award
Date
CO4
Cost to
Complete
Total
Cost
Target
Value of
Contract
0
NONE
300 1Q FY03
0
300
0
0
NONE
300 1Q FY03
0
340
0
0
NONE
100 1Q FY03
0
100
0
700
0
740
0
Remarks: JTCOPS - Performing Activities & Locations: SBCCOM - Natick, MA; SBCCOM - Edgewood, MD; Brooks AFB - San Antonio, TX; NSWCDD - Dahlgren, VA;
MARCORSYSCOM - Quantico, VA; CECOM - Ft. Belvoir, VA
III. Test and Evaluation: Not applicable
Project CO4
Page 39 of 112 Pages
UNCLASSIFIED
Exhibit R-3 (PE 0603884BP)
UNCLASSIFIED
DATE
CBDP PROJECT COST ANALYSIS (R-3 Exhibit)
BUDGET ACTIVITY
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
IV. Management Services
JTCOPS
PM/MS S - Block I Overall
Program Management and
Integrated Product Team Chair
Responsibilities
PM/MS SB - Block I Integrated
Product Team Participation
Subtotal IV. Management
Services:
February 2002
Contract
Method &
Type
Allot
PO
Performing Activity &
Location
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
US
NF
CC
Total
PYs
Cost
FY2001
Cost
FY2001
Award
Date
FY2002
Cost
FY2002
Award
Date
FY2003
Cost
FY2003
Award
Date
CO4
Cost to
Complete
Total
Cost
Target
Value of
Contract
SBCCOM - Natick, MA
U
0
470 1Q FY01
0
NONE
200 1Q FY03
0
670
0
See Remarks
U
0
944 1Q FY01
0
NONE
290 1Q FY03
0
1234
0
490
0
1904
0
1414
0
Remarks: JTCOPS - Performing Activities & Locations: SBCCOM - Edgewood, MD; Brooks AFB - San Antonio, TX; NSWCDD - Dahlgren, VA; MARCORSYSCOM - Quantico, VA
TOTAL PROJECT COST:
Project CO4
0
1454
Page 40 of 112 Pages
UNCLASSIFIED
0
4390
0
5844
Exhibit R-3 (PE 0603884BP)
UNCLASSIFIED
DATE
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2A Exhibit)
BUDGET ACTIVITY
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
COST (In Thousands)
CP4
February 2002
COUNTERPROLIFERATION SUPPORT (DEMVAL)
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
CP4
FY 2001
FY 2002
FY 2003
FY 2004
FY 2005
FY 2006
FY 2007
Cost to
Actual
Estimate
Estimate
Estimate
Estimate
Estimate
Estimate
Complete
15709
15243
13423
20442
21137
24459
Total Cost
25516 Continuing Continuing
A. Mission Description and Budget Item Justification:
Project CP4 COUNTERPROLIFERATION SUPPORT (DEMVAL): Providing full dimensional protection to deployed forces and critical
fixed sites, to include Aerial Ports of Debarkation (APODs) and Sea Ports of Debarkation (SPODs), under threat of chemical or biological attack
is one of the highest Commanders-in-Chief (CINC) priorities. Joint Vision 2010 states that power projection from the U.S. - achieved through
rapid strategic mobility and enabled by overseas presence - will likely remain the fundamental concept of our future force. Fixed installations
(seaports, aerial ports, logistics nodes, etc.) are critical to this mode of operation and are especially vulnerable to attack with Chemical and
Biological (CB) weapons. Future adversaries will likely use CB weapons to deny U.S. and Allied use of these facilities. U.S. forces, both mobile
and at fixed sites, must be able to survive CB attacks and quickly recover to continue operations. This project supports the accelerated fielding of
operational capabilities (technology, Concept of Operations (CONOPS), and automation tools) to CINCs through the Advanced Concept
Technology Demonstration (ACTD) process.
The Joint Biological Remote Early Warning System (JBREWS) ACTD, completed in FY01, attempted to address the need for an early warning,
detection and identification of Biological Warfare (BW) agents in assembly areas. The primary requirement of the sponsoring CINC was to have
an interim residual capability to detect, identify, and warn forces who may be exposed to BW agents. The JBREWS ACTD Military Utility
Assessment was conducted by USEUCOM in September 2000. The JBREWS components did not demonstrate sufficient maturity and reliability
to justify residual status. Technologies and detection strategies were transitioned to other biological detection systems in development and
acquisition.
Project CP4
Page 41 of 112 Pages
UNCLASSIFIED
Exhibit R-2 (PE 0603884BP)
UNCLASSIFIED
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2A Exhibit)
BUDGET ACTIVITY
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
DATE
February 2002
PE NUMBER AND TITLE
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
CP4
The Restoration of Operations (RestOps) ACTD investigates the impact of technology and CONOPS on restoring operating tempo at an airfield
following a CB attack. RestOps are those pre/during/post attack actions necessary to protect against and then immediately react to the
consequences of a CB attack on an airfield so that the facility can resume functioning with a minimum of down time. This ACTD will provide
technology, software support, and techniques and procedures so that an air base commander can minimize the impact of a CB attack on military
operations.
The Contamination Avoidance at Sea Ports of Debarkation (CASPOD) ACTD provides technologies, tools, tactics and procedures for the
recovery of throughput operations after a chemical or biological attack at a seaport during times of a major logistics operation.
The Joint Multi-Mission Advanced NBC system (JMANS) program, also an ACTD candidate for FY01 which was not approved, was to
provide Joint Task Force Commanders with an early entry NBC detection, warning and reporting capability.
Project CP4
Page 42 of 112 Pages
UNCLASSIFIED
Exhibit R-2 (PE 0603884BP)
UNCLASSIFIED
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2A Exhibit)
BUDGET ACTIVITY
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
DATE
February 2002
PE NUMBER AND TITLE
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
CP4
FY 2001 Accomplishments:
407 JBREWS ACTD - Conducted in-service engineering for product improvement of the JBREWS Sample Identification
Unit (SIU), power systems, and C4I, and support with modeling.
·
·
·
·
724 JBREWS ACTD - Provided operational and training SIU assay cartridges for the Operational Testing Period.
1927 JMANS - Initiated multi-mission sensor field trials to demonstrate CB detection capabilities with radar systems.
3400 RestOps ACTD - Completed Joint Chemical Field Trials (development tests) and technology assessments on RestOps
selected technologies at Dugway Proving Ground.
·
·
1400 RestOps ACTD - Conducted CONOPS validation for future use in the RestOps preliminary and final demonstrations.
·
·
2218 RestOps ACTD - Conducted the RestOps Air Base baseline exercise.
1871 RestOps ACTD - Began procurement on selected decontamination, detection, protection, medical countermeasures, and
sensor integration equipment/systems for the RestOps limited utility assessments, preliminary, and final demonstrations.
1443 RestOps ACTD - Conducted user Operational/Functional Testing for Limited Utility Assessment (LUA) of the RestOps
selected technologies satisfactorily making it through the Joint Chemical Field Trials at Dugway Proving Ground.
·
Total
2319 RestOps ACTD - Continued technology selection support, initiate procurement activity support, begin policy initiatives,
continue information technology integration efforts and initiate planning for the RestOps technology transition.
15709
Project CP4
Page 43 of 112 Pages
UNCLASSIFIED
Exhibit R-2 (PE 0603884BP)
UNCLASSIFIED
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2A Exhibit)
BUDGET ACTIVITY
DATE
February 2002
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
CP4
FY 2002 Planned Program:
550 RestOps ACTD - Initiate user training on new technologies in preparation for RestOps preparatory and final
demonstrations.
·
·
·
620 RestOps ACTD - Conduct user preliminary demonstrations at RestOps Operational Manager selected Air Bases.
610 RestOps ACTD - Complete procurement of selected technologies for decontamination, detection, protection, medical
countermeasures, and sensor integration hardware and software.
·
4980 RestOps ACTD - Continue procurement support, policy initiatives, transition planning, and information technology
integration support.
·
2725 RestOps ACTD - Conduct technology systems integration and systems tests, final CONOPS evaluation, and complete
Limited Utility Assessment reports.
·
1833 CASPOD ACTD - Develop the Management Plan, management structure, and methodologies for technology selection
analysis, chemical field-test assessment, and operational capability assessment for use during CASPOD.
Begin procurement on selected decontamination, detection, protection, medical countermeasures and sensor integration
equipment/systems for the CASPOD limited utility assessments, preliminary and final demonstrations.
And Conduct technology selection support, initiate procurement activity support, begin policy initiatives, continue
information technology integration efforts and initiate planning for the CASPOD technology transition.
·
Project CP4
1833 CASPOD ACTD - Develop site chemical and biological exercise scenario in preparation for the CASPOD baselining
exercise. Conduct scenario and evaluation development for use in the CASPOD baselining exercise, preliminary and
final demonstrations. Conduct CONOPS validation for future use in the CASPOD preliminary and final
demonstrations. Conduct a series of tabletop exercises to establish the CASPOD baseline.
Page 44 of 112 Pages
UNCLASSIFIED
Exhibit R-2 (PE 0603884BP)
UNCLASSIFIED
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2A Exhibit)
BUDGET ACTIVITY
DATE
February 2002
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
CP4
FY 2002 Planned Program (Cont):
1834 CASPOD ACTD - Conduct user operational/functional testing for limited utility assessments (LUA) of the CASPOD
selected technologies satisfactorily making it through the Joint Chemical Field Trials at Dugway Proving Ground.
·
·
Total
258 SBIR - Small Business Innovative Research.
15243
FY 2003 Planned Program:
959 CASPOD - Conduct user preliminary demonstration at CASPOD Operational Manager selected seaports.
·
·
959 CASPOD - Conduct the CASPOD final user demonstration on new technologies taking it through the preliminary
demonstration.
·
959 CASPOD - Complete procurement of selected technologies for decontamination, detection, protection, medical
countermeasures, and sensor integration hardware and software.
·
959 CASPOD - Continue procurement support, policy initiatives, transition planning, and information technology integration
support.
·
959 CASPOD - Conduct technology systems integration and systems tests, final CONOPs evaluation, and complete Limited
Utility Assessment reports.
·
958 CASPOD - Initiate user training on new technologies in preparation for preliminary and final demonstrations.
Complete user training for final demonstrations at the OM selected seaports.
·
550 RestOps ACTD - Complete user training for final demonstrations at the Operational Manager selected airbases.
Project CP4
Page 45 of 112 Pages
UNCLASSIFIED
Exhibit R-2 (PE 0603884BP)
UNCLASSIFIED
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2A Exhibit)
BUDGET ACTIVITY
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
DATE
February 2002
PE NUMBER AND TITLE
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
CP4
FY 2003 Planned Program (Cont):
2100 RestOps ACTD - Conduct the RestOps final user demonstration on new technologies taking it through the preliminary
demonstration.
·
·
2603 RestOps ACTD - Initiate planning, procurement, and contractor logistics support services for residual support on
Operational Manager selected technologies.
·
·
1500 RestOps ACTD - Finalize policy initiatives and complete information technology integration.
Total
917 RestOps ACTD - Develop and complete Military Utility Assessment (MUA) report and complete CONOPS documents.
13423
Project CP4
Page 46 of 112 Pages
UNCLASSIFIED
Exhibit R-2 (PE 0603884BP)
UNCLASSIFIED
DATE
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2A Exhibit)
BUDGET ACTIVITY
February 2002
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
CP4
B. Other Program Funding Summary:
FY 2001
FY 2002
FY 2003
FY 2004
FY 2005
FY 2006
FY 2007
To
Compl
Total
Cost
BJ4 BIOLOGICAL DEFENSE (DEMVAL)
5765
1560
3661
19163
19329
0
0
0
49478
BJ5 BIOLOGICAL DEFENSE (EMD)
7575
12803
14660
17977
17315
37632
35708
Cont
Cont
CP3 COUNTERPROLIFERATION SUPPORT (ADV
TECH DEV)
9944
12492
11738
5327
5368
4697
4242
Cont
Cont
0
0
0
0
0
0
0
0
0
4284
1913
2010
1850
1894
2251
2301
Cont
Cont
26192
3865
0
0
0
0
0
0
30057
CP5 COUNTERPROLIFERATION SUPPORT (EMD)
JPO210 CRITICAL REAGENTS PROGRAM (CRP)
JPO230 PORTAL SHIELD EQUIPMENT
C. Acquisition Strategy:
ACTDs
Utilize non-traditional acquisition Advanced Concept Technology Demonstration (ACTD) to rapidly provide the CINC
with operational capabilities to counter the battlefield effects of chemical and biological attacks, to include the
development of concepts of operation and doctrine.
ARTEMIS
Moved to Contamination Avoidance.
Project CP4
Page 47 of 112 Pages
UNCLASSIFIED
Exhibit R-2 (PE 0603884BP)
UNCLASSIFIED
DATE
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2A Exhibit)
BUDGET ACTIVITY
February 2002
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
D. Schedule Profile:
FY 2000
1
2
3
4
FY 2001
1
2
3
4
FY 2002
1
2
3
4
FY 2003
1
2
3
4
FY 2004
1
2
3
4
FY 2005
1
2
3
4
CP4
FY 2006
1
2
3
4
FY 2007
1
2
3
ARTEMIS
Concept Exploration
Analysis of Alternatives
>>
1Q
2Q
4Q
Milestone Component Advanced
Development (CAD)
1Q
Milestone C Low Rate Initial Production
(LRIP)
1Q
Component Advanced Development
1Q
BLK I - Release Draft Request for Proposal
(RFP)
4Q
3Q
BLK I - Milestone B Decision
1Q
BLK I - Release Request for Proposal
(RFP)
1Q
3Q
BLK I - Award Contract (Prototype)
3Q
BLK I - Prototype Hardware/Software
Development
3Q
3Q
BLK I - System Requirements Review
(SRR)
1Q
BLK I - Integrated Baseline Review (IBR)
1Q
Project CP4
Page 48 of 112 Pages
UNCLASSIFIED
Exhibit R-2 (PE 0603884BP)
4
UNCLASSIFIED
DATE
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2A Exhibit)
BUDGET ACTIVITY
February 2002
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
D. Schedule Profile (cont):
FY 2000
1
2
3
4
FY 2001
1
2
3
4
FY 2002
1
2
3
4
FY 2003
1
2
3
4
FY 2004
1
2
3
4
FY 2005
1
2
3
4
CP4
FY 2006
1
2
3
4
FY 2007
1
2
3
ARTEMIS (Cont)
BLK I - System Function Requirements
(SFR)
3Q
BLK I - Early Prototypes Delivered
3Q
BLK I - Prototype Developmental Testing
(DT I)
3Q 4Q
BLK I - Early Operational Assessment
1Q
BLK I - Advanced Prototypes Delivered
2Q
BLK I - Prototype Developmental Testing
(DT II)
2Q
BLK I - Operational Assessment (OA)
3Q
Developmental Test I (DT I) LAV variant
2Q
BLK I - Award Low Rate Initial Production
(LRIP) Contract / Option
2Q
INTCBATD
Scenario/Exercise Development
Joint Chemical Fields Trials
Concept of Operations (CONOPS)
Development
Project CP4
4Q
3Q
4Q
Page 49 of 112 Pages
UNCLASSIFIED
Exhibit R-2 (PE 0603884BP)
4
UNCLASSIFIED
DATE
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2A Exhibit)
BUDGET ACTIVITY
February 2002
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
D. Schedule Profile (cont):
FY 2000
1
2
3
4
FY 2001
1
2
3
4
FY 2002
1
2
3
4
FY 2003
1
2
3
4
FY 2004
1
2
3
4
FY 2005
1
2
3
4
CP4
FY 2006
1
2
3
4
FY 2007
1
2
3
INTCBATD (Cont)
Concept of Operations (CONOPS)
Validation
1Q 2Q
Baseline Exercise
3Q
Procurement
3Q
Training
4Q
2Q
Preliminary Demonstration
2Q
4Q
Joint Warfighting Experiment (JWE)/Final
Demonstration
4Q
JBREWS
Conduct JBREWS Advanced Concept
Technology Demonstration (ACTD)
Demonstration
4Q 1Q
JMANS
Advanced Concept Technology
Demonstration (ACTD) Development
1Q
Conduct Radar Multimission Sensor Field
Trials
4Q
3Q 4Q
RESTOPS
Scenario/Exercise Development
Project CP4
2Q
2Q
Page 50 of 112 Pages
UNCLASSIFIED
Exhibit R-2 (PE 0603884BP)
4
UNCLASSIFIED
DATE
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2A Exhibit)
BUDGET ACTIVITY
February 2002
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
D. Schedule Profile (cont):
FY 2000
1
2
3
4
FY 2001
1
2
3
4
FY 2002
1
2
3
4
FY 2003
1
2
3
4
FY 2004
1
2
3
4
FY 2005
1
2
3
4
CP4
FY 2006
1
2
3
4
FY 2007
1
2
3
RESTOPS (Cont)
Joint Chemical Field Trials
3Q
1Q
Concept of Operations (CONOPS)
Development
Concept of Operations (CONOPS)
Validation
1Q
1Q 2Q
Functional Test
2Q
Baseline Exercise
2Q
Procurement
Training
2Q
3Q
1Q
2Q
1Q
Osan AB Demonstration Vignette
3Q
DPG Decon Demonstration Vignette
3Q
DPG Medical Demonstration Vignette
4Q
Joint Warfighting Experiment (JWE)/Final
Demonstration
2Q
Fielding Support (CLS)
2Q
Project CP4
Page 51 of 112 Pages
UNCLASSIFIED
4Q
Exhibit R-2 (PE 0603884BP)
4
UNCLASSIFIED
DATE
CBDP PROJECT COST ANALYSIS (R-3 Exhibit)
BUDGET ACTIVITY
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
I. Product Development
Contract
Method &
Type
Performing Activity &
Location
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
US
NF
CC
Total
PYs
Cost
FY2001
Cost
FY2001
Award
Date
FY2002
Cost
FY2002
Award
Date
INTCBATD
HW S - Procure CASPOD
Technologies
PO
Army-Soldier Biological
Chemical Command,
APG, MD
U
0
0
NONE
0
NONE
RESTOPS
HW S - Procure RESTOPS
Technologies
MIPR
Army- Soldier Biological
Chemical Command,
APG, MD
U
0
1871
Oct-00
610
Oct-01
MIPR
Army- Soldier Biological
Chemical Command,
APG, MD
U
0
0
NONE
238 1Q FY02
0
1871
HW S - Procure CASPOD
Technologies
Subtotal I. Product Development:
February 2002
848
FY2003
Cost
FY2003
Award
Date
1900 1Q FY03
CP4
Cost to
Complete
Total
Cost
Target
Value of
Contract
0
1900
0
0
NONE
0
2481
0
0
NONE
0
238
0
0
4619
1900
Remarks:
Project CP4
Page 52 of 112 Pages
UNCLASSIFIED
Exhibit R-3 (PE 0603884BP)
UNCLASSIFIED
DATE
CBDP PROJECT COST ANALYSIS (R-3 Exhibit)
BUDGET ACTIVITY
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
II. Support Costs
Contract
Method &
Type
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
Performing Activity &
Location
US
NF
CC
Total
PYs
Cost
FY2001
Cost
INTCBATD
ILS S - Training for Preliminary
and Final Demonstrations
Allot
Army - US Army
Chemical School, Ft
Leonard Wood, MO
U
0
JBREWS
ES SB - Sample Identification Unit
Inservice Engineering
MIPR
NSWC, Dahlgren, VA
U
0
SS/CPFF SOBRAN, Edgewood,
MD
C
JMANS
TD/D SB - JMANS CONOPS
Development
February 2002
FY2001
Award
Date
0
NONE
FY2002
Cost
FY2002
Award
Date
FY2003
Cost
FY2003
Award
Date
0
NONE
250 1Q FY03
407 1Q FY01
0
NONE
0
0
100 2Q FY01
0
NONE
CP4
Cost to
Complete
Total
Cost
Target
Value of
Contract
0
250
0
NONE
0
407
0
0
NONE
0
100
0
ES S - JMANS CONOPS
Development
MIPR
NSWC, Dahlgren, VA
U
0
180 1Q FY02
0
NONE
0
NONE
0
180
0
ES SB - JMANS CONOPS
Development
MIPR
CECOM, Ft. Monmouth,
NJ
U
0
150 1Q FY02
0
NONE
0
NONE
0
150
0
Allot
Army - US Army
Chemical School, Ft
Leonard Wood, MO
U
0
0
NONE
550
Oct-01
550
Oct-02
0
1100
0
ILS S - Residual Support
Allot
Army - Soldier
Biological Chemical
Command, APG. MD
U
0
0
NONE
0
NONE
2603
Oct-02
0
2603
0
ES S - Systems Integration and
Integration Testing
Allot
Army - Soldier
Biological Chemical
Command, APG, MD
U
0
0
NONE
1667
Oct-01
0
NONE
0
1667
0
RESTOPS
ILS S - Training for Preliminary
and Final Demonstrations
Project CP4
Page 53 of 112 Pages
UNCLASSIFIED
Exhibit R-3 (PE 0603884BP)
UNCLASSIFIED
DATE
CBDP PROJECT COST ANALYSIS (R-3 Exhibit)
BUDGET ACTIVITY
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
II. Support Costs - Cont.
TD/D S - Military Utility
Assessment Report and CONOPS
Documents
February 2002
Contract
Method &
Type
Allot
Performing Activity &
Location
Air Force - AF
Operational Test Center,
Albuquerque, NM
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
US
NF
CC
Total
PYs
Cost
U
Subtotal II. Support Costs:
FY2001
Cost
FY2001
Award
Date
0
0
0
837
FY2002
Cost
NONE
FY2002
Award
Date
0
NONE
2217
FY2003
Cost
917
FY2003
Award
Date
CP4
Cost to
Complete
Oct-02
4320
Total
Cost
Target
Value of
Contract
0
917
0
7374
0
Remarks:
III. Test and Evaluation
INTCBATD
OTHT SB - Complete Tests on
Selected Technologies in Joint
Chemical Field Trials
OTHT S - Conduct Operational
and Functional Tests During
Limited Utility Tests
Contract
Method &
Type
MIPR
Army-Dugway Proving
Ground, Dugway, Utah
PO
Air Force - AF
Operational Test Center,
Albuquerque, NM
OTHT SB - Conduct CASPOD
Chemical Biological Defense
Concepts of Operations Validation
MIPR
OTHT SB - Conduct Preliminary
Demonstration at Blount Is, FL
and Final Demonstration at Mina
Sulma, Bahrain
PO
Project CP4
Performing Activity &
Location
US
NF
CC
U
Total
PYs
Cost
FY2001
Cost
FY2001
Award
Date
FY2002
Cost
FY2002
Award
Date
FY2003
Cost
FY2003
Award
Date
Cost to
Complete
Total
Cost
Target
Value of
Contract
0
0
NONE
0
NONE
1000 1Q FY03
0
1000
0
0
0
NONE
0
NONE
339 1Q FY03
0
339
0
US Central Command,
MacDill AFB, Tampa,
FL
U
0
0
NONE
0
NONE
250 1Q FY03
0
250
0
Air Force - AF
Operational Test Center,
Albuquerque, NM
U
0
0
NONE
0
NONE
1500 1Q FY03
0
1500
0
Page 54 of 112 Pages
UNCLASSIFIED
Exhibit R-3 (PE 0603884BP)
UNCLASSIFIED
DATE
CBDP PROJECT COST ANALYSIS (R-3 Exhibit)
BUDGET ACTIVITY
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
III. Test and Evaluation - Cont.
February 2002
Contract
Method &
Type
Performing Activity &
Location
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
US
NF
CC
Total
PYs
Cost
FY2001
Cost
FY2001
Award
Date
JBREWS
OTE S - Purchase Operational
Testing Period Assay Cartridges
C/FFP
ACS Defense Inc.,
Alexandria, VA
C
0
724
JMANS
ES S - Contract Support for SDD
Phase
MIPR
CECOM, Ft. Monmouth,
NJ
U
0
Oct-00
FY2002
Cost
FY2002
Award
Date
FY2003
Cost
FY2003
Award
Date
CP4
Cost to
Complete
Total
Cost
Target
Value of
Contract
0
NONE
0
NONE
0
724
0
374 2Q FY01
0
NONE
0
NONE
0
374
0
OTHT SB - Field Trials for the
Radar Multimission Sensor
SS/CPFF TAMSCO, Edgewood,
MD
C
0
192 2Q FY01
0
NONE
0
NONE
0
192
0
OTHT SB - Field Trials for Radar
Multimission Sensor
SS/CPFF DYCOR, Havre de
Grace, MD
C
0
51 2Q FY01
0
NONE
0
NONE
0
51
0
RESTOPS
OTHT SB - Complete Tests on
Selected Technologies in Joint
Chemical Field Trials
MIPR
Army- Dugway Proving
Ground, Dugway, Utah
U
0
3400
Oct-00
0
NONE
0
NONE
0
3400
0
OTHT S - Conduct Operational
and Functional Tests During
Limited Utility Tests
Allot
Air Force - AF
Operational Test Center,
Albuquerque, NM
U
0
1443
Oct-00
339
Oct-01
0
NONE
0
1782
0
OTHT S - Conduct Baselining
Exercise on Airbase Operations
Allot
Air Force - AF
Operational Test Center,
Albuquerque, NM
U
0
2218
Oct-00
0
NONE
0
NONE
0
2218
0
OTHT SB - Conduct Airbase
Chemical Biological Defense
Concepts of Operation Validation
MIPR
Air Force - Pacifica Air
Forces, Hickam AF,
Hawaii
U
0
1400
Oct-00
250
Oct-01
0
NONE
0
1650
0
Project CP4
Page 55 of 112 Pages
UNCLASSIFIED
Exhibit R-3 (PE 0603884BP)
UNCLASSIFIED
DATE
CBDP PROJECT COST ANALYSIS (R-3 Exhibit)
BUDGET ACTIVITY
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
III. Test and Evaluation - Cont.
Contract
Method &
Type
Performing Activity &
Location
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
US
NF
CC
Total
PYs
Cost
FY2001
Cost
FY2001
Award
Date
OTHT SB - Conduct Preliminary
and Final Demonstrations at Osan
AB, Korea
Allot
Air Force - AF
Operational Test Center,
Albuquerque, NM
U
0
0
NONE
OTHT SB - Complete Tests on
Selected Technologies in Joint
Chemical Field Trials
MIPR
Army-Dugway Proving
Ground, Dugway, UT
U
0
0
NONE
OTHT S - Conduct Operational
and Functional Test During
Limited Utility Tests
Allot
Air Force - AF
Operational Test Center,
Albuquerque, NM
U
0
0
OTHT S - Conduct Baselining
Exercise on Seaport Operations
Allot
Air Force - AF
Operational Test Center,
Albuquerque, NM
U
0
OTHT SB - Conduct CASPOD
Chemical Biological Defense
Concepts of Operation Validation
MIPR
US Central Command,
MacDill AFB, Tampa,
FL
U
Subtotal III. Test and Evaluation:
February 2002
FY2002
Cost
2590
FY2002
Award
Date
FY2003
Award
Date
Cost to
Complete
Total
Cost
Target
Value of
Contract
2100
Oct-02
0
4690
0
500 2Q FY02
0
NONE
0
500
0
NONE
1443 2Q FY02
0
NONE
0
1443
0
0
NONE
500 2Q FY02
0
NONE
0
500
0
0
0
NONE
500 2Q FY02
0
NONE
0
500
0
0
9802
0
21113
6122
Oct-01
FY2003
Cost
CP4
5189
Remarks:
Project CP4
Page 56 of 112 Pages
UNCLASSIFIED
Exhibit R-3 (PE 0603884BP)
UNCLASSIFIED
DATE
CBDP PROJECT COST ANALYSIS (R-3 Exhibit)
BUDGET ACTIVITY
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
IV. Management Services
INTCBATD
PM/MS S - Perform Program
Management for CASPOD ACTD
February 2002
Contract
Method &
Type
Performing Activity &
Location
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
US
NF
CC
Total
PYs
Cost
FY2001
Cost
FY2001
Award
Date
FY2002
Cost
FY2002
Award
Date
FY2003
Cost
FY2003
Award
Date
C/FP
Defense Group
Incorporated,
Alexandria, VA
C
0
0
NONE
0
NONE
300
Allot
DTRA, Alexandria, VA
U
0
0
NONE
0
NONE
214 1Q FY03
SBCCOM, APG, MD
U
0
0
NONE
0
C/FP
Defense Group
Incorporated,
Alexandria, VA
C
0
1625
Oct-00
3000
Oct-01
PM/MS S - Perform Program
Management for RestOps
Allot
DTRA, Alexandria, VA
U
0
694
Oct-00
479
Oct-01
Advanced LRUs and Breadboard
Allot
Defense Group
Incorporated,
Alexandria, VA
C
0
0
NONE
PM/MS S - Perform Program
Management for CASPOD ACTD
Allot
DTRA, Alexandria, VA
U
0
0
PO
HQ AMC, Alexandria,
VA
U
0
0
PM/MS S - Perform Program
Management for CASPOD
JMANS
PM/MS S - JMANS Multiservice
Program Administration
RESTOPS
PM/MS S - Perform Program
Management for RESTOPS ACTD
ZSBIR
SBIR/STTR - Aggregated from
ZSBIR-SBIR/STTR
Project CP4
PO
Cost to
Complete
Total
Cost
Target
Value of
Contract
0
300
0
0
214
0
NONE
0
880
0
0
NONE
0
4625
0
1500
Oct-02
0
2673
0
1625 1Q FY02
0
NONE
0
1625
0
NONE
694 2Q FY02
0
NONE
0
694
0
NONE
258 2Q FY02
0
NONE
0
258
0
880 1Q FY01
Page 57 of 112 Pages
UNCLASSIFIED
Oct-02
CP4
Exhibit R-3 (PE 0603884BP)
UNCLASSIFIED
DATE
CBDP PROJECT COST ANALYSIS (R-3 Exhibit)
BUDGET ACTIVITY
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
IV. Management Services - Cont.
Subtotal IV. Management
Services:
February 2002
Contract
Method &
Type
Performing Activity &
Location
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
US
NF
CC
Total
PYs
Cost
FY2001
Cost
FY2001
Award
Date
FY2002
Cost
FY2002
Award
Date
FY2003
Cost
FY2003
Award
Date
CP4
Cost to
Complete
Total
Cost
0
3199
6056
2014
0
11269
0
15709
15243
13423
0
44375
Target
Value of
Contract
Remarks:
TOTAL PROJECT COST:
Project CP4
Page 58 of 112 Pages
UNCLASSIFIED
Exhibit R-3 (PE 0603884BP)
UNCLASSIFIED
DATE
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2A Exhibit)
BUDGET ACTIVITY
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
COST (In Thousands)
DE4
February 2002
DECONTAMINATION SYSTEMS (DEMVAL)
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
DE4
FY 2001
FY 2002
FY 2003
FY 2004
FY 2005
FY 2006
FY 2007
Cost to
Actual
Estimate
Estimate
Estimate
Estimate
Estimate
Estimate
Complete
3368
6143
6972
12378
14220
3997
Total Cost
3992 Continuing Continuing
A. Mission Description and Budget Item Justification:
Project DE4 DECONTAMINATION SYSTEMS (DEMVAL): This DEMVAL funding supports Component Advanced Development and
System Integration (CAD/SI) of decontamination systems utilizing solutions that will remove and/or detoxify contaminated material without
damaging combat equipment, personnel, or the environment. Decontamination systems provide a force restoration capability for units that
become contaminated. Development efforts will provide systems with reduced operational impact, reduced logistics burden, reduced costs,
increased safety, and minimized environmental effect over currently fielded decontaminants. This funding supports the Joint Service Fixed Site
Decontamination (JSFXD) and the Joint Service Sensitive Equipment Decontamination (JSSED) programs.
The JSFXD system consists of a family of decontaminants and family of applicators that provide each service with the capability to decontaminate
fixed sites to restore mission operations. These items will be used to decontaminate equipment, personnel, and vital areas to sustain critical cargo
flow and operation tempo at ports, airfields, logistic nodes, and key command and control centers. The program is divided into four blocks.
Block I will field decontaminants that will be used with integral or existing applicators. Block II will field any additional applicators and
containment systems required to provide the full fixed site decontamination capability (excluding Block III). Block III will provide a Food and
Drug Administration (FDA) approved capability to decontaminate skin/casualties with open wounds. Block IV will address requirements that
have been trade-offs or are currently ill defined, inserting technology as it matures to the point of being cost effective.
Project DE4
Page 59 of 112 Pages
UNCLASSIFIED
Exhibit R-2 (PE 0603884BP)
UNCLASSIFIED
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2A Exhibit)
BUDGET ACTIVITY
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
DATE
February 2002
PE NUMBER AND TITLE
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
DE4
The JSSED system will fill an immediate need to decontaminate chemical and biological warfare agents from sensitive equipment, vehicle/aircraft
interiors, and associated cargo, as defined in the draft Joint Service Operational Requirements Document (JSORD) for the JSSED. The JSSED
will be a dual technology development program; one technology to decontaminate sensitive items/equipment and a second technology to
decontaminate vehicle/aircraft interiors. The JSSED will utilize a three block approach to address individual key capabilities to reduce program
risk and support production schedule. Block I will do sensitive equipment/items decontamination; Block II will do aircraft/vehicle interior
decontamination; and, Block III will do aircraft/vehicle interior decontamination "on-the-move."
SORBDECON provides a reactive sorbent powder technology and a family of applicators for immediate decontamination. Sorbent replaces the
XE555 resin in the M295 Decontamination Kit for wipe down procedures. The sorbent and a dispenser system will replace M11's and M13's
used for immediate decontamination, and associated Decontaminating Solution 2 (DS2) in operator spray down procedures. The Sorbent Decon
System will be more reactive towards Chemical Warfare (CW) agents than the M295 Kit using XE555 Resin, therefore reducing the hazard
associated with the spent decontaminant. The sorbent will be more compatible with Mission Oriented Protective Posture (MOPP) and other
materials than the currently fielded DS2. This program completed the RDTE phase in FY2001.
Project DE4
Page 60 of 112 Pages
UNCLASSIFIED
Exhibit R-2 (PE 0603884BP)
UNCLASSIFIED
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2A Exhibit)
BUDGET ACTIVITY
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
DATE
February 2002
PE NUMBER AND TITLE
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
DE4
FY 2001 Accomplishments:
568 JSFXD - Completed performance specifications to support procurement for all blocks and technical documentation
(Test Reports and Test Plans) to support a MS B decision for Block I.
·
·
·
336 JSFXD - Initiated MS B documentation for Block II. Prepared solicitation package Block III.
·
·
·
420 JSSED - Completed performance specifications and Request for Proposal to support development contract for Block I.
·
·
201 SORBDECON - Completed baseline toxicity testing of sorbent material.
Total
Project DE4
976 JSFXD - Initiated test methodology development and initial toxicology testing to support downselect and FDA approval
of Block III skin/casualty decontaminants.
379 JSSED - Conducted source selection evaluation board to select Block I candidate systems.
232 JSSED - Prepared and submitted Block I Milestone documentation, which included Test and Evaluation Master Plan,
System Acquisition Master Plan, and Acquisition Program Baseline.
256 SORBDECON - Completed development and support of Milestone III decision documentation for operator's spray
down system on equipment.
3368
Page 61 of 112 Pages
UNCLASSIFIED
Exhibit R-2 (PE 0603884BP)
UNCLASSIFIED
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2A Exhibit)
BUDGET ACTIVITY
DATE
February 2002
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
DE4
FY 2002 Planned Program:
577 JSFXD - Continue toxicology testing and other evaluations necessary for FDA approval to support downselect of Block
III skin/casualty decontaminants.
·
·
·
·
1430 JSFXD - Award system integration contract(s) for Block II family of applicators system to develop prototype applicator
and containment systems for evaluation (15 systems at average cost of $100K).
941 JSFXD - Perform Early Operational Assessment and initiate Developmental Testing (DT) of Block II family of
applicator systems.
2500 JSSED - Award Block I competitive contract to deliver three system models from each of two contractors and
investigate design improvements to meet military requirements. (Total of six prototypes at $150K each).
·
591 JSSED - Conduct assessments evaluating performance and procedures in a chemical environment. Conduct assessments
of the effectiveness of interior building areas for use as chemical rest and relief areas.
·
104 SBIR - Small Business Innovative Research.
Total
6143
FY 2003 Planned Program:
248 JSSED - Conduct Block I program Interim Progress Review (IPR) to finalize Block I technology and system design.
·
·
·
Project DE4
3457 JSSED - Award contract to fabricate Block I developmental test systems which implement design improvements from
the prior year competitive prototypes.
2667 JSSED - Initiate pre-production Block I system test design.
Page 62 of 112 Pages
UNCLASSIFIED
Exhibit R-2 (PE 0603884BP)
UNCLASSIFIED
DATE
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2A Exhibit)
BUDGET ACTIVITY
February 2002
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
DE4
FY 2003 Planned Program (Cont):
500 JSSED - Prepare and submit Block II/III Milestone B documentation, which includes Test and Evaluation Master Plan,
System Acquisition Master Plan, and Acquisition Program Baseline.
·
·
Total
100 JSSED - Prepare Request for Proposal for Block II/III combined development effort.
6972
B. Other Program Funding Summary:
FY 2001
FY 2002
FY 2003
FY 2004
FY 2005
FY 2006
FY 2007
To
Compl
Total
Cost
DE5 DECONTAMINATION SYSTEMS (EMD)
3746
2498
4981
4925
897
4996
2993
Cont
Cont
G47001 MODULAR DECON SYSTEM
2450
4997
5007
5098
4973
4987
0
0
27512
JN0010 JOINT SERVICE FIXED SITE DECON
(JSFXD)
0
1515
2001
7508
6579
0
0
0
17603
JN0016 JOINT SERVICE SENSITIVE EQUIPMENT
DECON
0
0
0
0
0
6074
12234
Cont
Cont
2726
8578
8553
266
0
0
0
0
20123
JN0018 SORBENT DECON
Project DE4
Page 63 of 112 Pages
UNCLASSIFIED
Exhibit R-2 (PE 0603884BP)
UNCLASSIFIED
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2A Exhibit)
BUDGET ACTIVITY
DATE
February 2002
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
DE4
C. Acquisition Strategy:
JSFXD
Block I: competitively procure COTS/NDI decontaminants and where required, integral applicators for
government/contractor test with options for production. Block II: competitive contract to develop applicator and
containment systems for government/contractor testing with options for production. Block III: competitive procurement
of COTS/NDI decontaminants with potential to meet FDA requirements for government testing with options for
production. Block IV provides the warfighter with capabilities that were traded off during Blocks I-III, or to meet those
requirements that are currently ill defined or underdefined, by inserting technology as it matures to the point of being cost
effective.
JSSED
Utilize a three block approach to address individual key capabilities to reduce program risk and support production
schedule. Block I: provide for sensitive equipment/items decontamination; Block II: provide for aircraft/vehicle interior
decontamination; and, Block III: provide for aircraft/vehicle interior decontamination "on-the-move." Blocks I-III:
in-house/contractor development and testing. Competitive contractor manufacture of production units.
SORBDECON
In-house/contractor development and testing. Competitive contractor manufacture of production units.
Project DE4
Page 64 of 112 Pages
UNCLASSIFIED
Exhibit R-2 (PE 0603884BP)
UNCLASSIFIED
DATE
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2A Exhibit)
BUDGET ACTIVITY
February 2002
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
D. Schedule Profile:
FY 2000
1
2
3
4
FY 2001
1
2
3
4
FY 2002
1
2
3
4
FY 2003
1
2
3
4
FY 2004
1
2
3
4
FY 2005
1
2
3
4
DE4
FY 2006
1
2
3
4
FY 2007
1
2
3
JSFXD
Block I - IV In Process Review (IPR)
1Q 2Q
Block I Milestone B
2Q
Block I Developmental Test
(DT)/Operational Test (OT)
2Q 3Q
Block I Milestone C
3Q
Block II Milestone B
1Q
Block II DT/Operational Test (OT) for
Family of Applicators
1Q
1Q
Block II Milestone C
3Q
Block III Tests for Downselect
3Q
Block III Milestone B
3Q
4Q
Block III Federal Drug Administration
(FDA) Clinical Testing
3Q
Block III Developmental Test/ Operational
Test (DT/OT)
3Q
Block III Milestone C
2Q
4Q
1Q
JSSED
Block I Concept Exploration
Project DE4
>>
4Q
Page 65 of 112 Pages
UNCLASSIFIED
Exhibit R-2 (PE 0603884BP)
4
UNCLASSIFIED
DATE
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2A Exhibit)
BUDGET ACTIVITY
February 2002
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
D. Schedule Profile (cont):
FY 2000
1
2
3
4
FY 2001
1
2
3
4
FY 2002
1
2
3
4
FY 2003
1
2
3
4
FY 2004
1
2
3
4
FY 2005
1
2
3
4
DE4
FY 2006
1
2
3
4
FY 2007
1
2
3
4
JSSED (Cont)
Prototype Developmental Testing (DT I)
>>
Block I Milestone B
4Q
2Q
Block I Competitive Prototype Contract
Award
2Q
Block I Contract Effort
2Q
Evaluate Candidate Block I Prototypes
4Q
4Q 1Q
Downselect Block I Prototype
1Q
Development of Pre-Production Block I
Units
2Q
4Q
Block I Prototype Developmental Testing
(DT)
1Q
Block II/III Milestone B
3Q
4Q
Block II/III Competitive Prototype Contract
1Q
Block I Milestone C Type Classification
4Q
1Q
SORBDECON
Engineering, Design, and Test
(EDT)/Operational Test (OT)
Milestone III for M100 SORBDECON
Project DE4
>> 2Q
3Q
Page 66 of 112 Pages
UNCLASSIFIED
Exhibit R-2 (PE 0603884BP)
UNCLASSIFIED
DATE
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2A Exhibit)
BUDGET ACTIVITY
February 2002
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
D. Schedule Profile (cont):
FY 2000
1
2
3
4
FY 2001
1
2
3
4
FY 2002
1
2
3
4
FY 2003
1
2
3
4
FY 2004
1
2
3
4
FY 2005
1
2
3
4
DE4
FY 2006
1
2
3
4
FY 2007
1
2
3
SORBDECON (Cont)
M100 SORBDECON Production Contract
Award
Project DE4
4Q
Page 67 of 112 Pages
UNCLASSIFIED
Exhibit R-2 (PE 0603884BP)
4
UNCLASSIFIED
DATE
CBDP PROJECT COST ANALYSIS (R-3 Exhibit)
BUDGET ACTIVITY
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
I. Product Development
JSFXD
OTHT SB - Multiwave LIDAR Demonstrate Component Advance
Development Tasks
JSSED
SW SB - JSSED - Block I
Prototype Systems (2 Contractors 3 Systems Each)
February 2002
Contract
Method &
Type
C/FPI
Performing Activity &
Location
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
US
NF
CC
Total
PYs
Cost
FY2001
Cost
FY2001
Award
Date
FY2002
Cost
FY2002
Award
Date
FY2003
Cost
FY2003
Award
Date
DE4
Cost to
Complete
Total
Cost
Target
Value of
Contract
TBS
C
0
0
NONE
1130
Feb-02
0
NONE
0
1130
0
C/CPFF TBS
C
0
0
NONE
2000
Feb-02
3457
Feb-03
0
5457
0
0
0
0
6587
Subtotal I. Product Development:
3130
3457
Remarks:
II. Support Costs
JSFXD
ES S - Contractor Support for
Family of Applicators Block II
Subtotal II. Support Costs:
Contract
Method &
Type
C/FFP
Performing Activity &
Location
SVERDRUP,
Woodbridge, VA.
US
NF
CC
C
Total
PYs
Cost
FY2001
Cost
FY2001
Award
Date
0
0
0
0
NONE
FY2002
Cost
300
300
FY2002
Award
Date
Dec-01
FY2003
Cost
FY2003
Award
Date
0
0
NONE
Cost to
Complete
Total
Cost
Target
Value of
Contract
0
300
0
300
Remarks:
Project DE4
Page 68 of 112 Pages
UNCLASSIFIED
Exhibit R-3 (PE 0603884BP)
0
UNCLASSIFIED
DATE
CBDP PROJECT COST ANALYSIS (R-3 Exhibit)
BUDGET ACTIVITY
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
III. Test and Evaluation
JSFXD
OTHT SB - FDA Evaluation of
Skin Decontaminants Blk III
February 2002
Contract
Method &
Type
Performing Activity &
Location
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
US
NF
CC
Total
PYs
Cost
FY2001
Cost
FY2001
Award
Date
FY2002
Cost
FY2002
Award
Date
FY2003
Cost
FY2003
Award
Date
DE4
Cost to
Complete
Total
Cost
Target
Value of
Contract
MIPR
USAMMDA, FT
DETRICK, MD.
U
0
962
Nov-00
477
Nov-01
0
NONE
0
1439
0
MIPR
TBS
U
0
0
NONE
700
Nov-01
0
NONE
0
700
0
JSSED
OTHT SB - JSSED - Block I
Testing
Various
TBS
U
0
0
NONE
591 3Q FY02
2667
Dec-02
0
3258
0
SORBDECON
OTHT SB - Conduct Toxicity
Testing of Sorbent Material
MIPR
SBCCOM, APG, MD
U
0
0
NONE
0
200
150
0
5597
OTHT SB - DT for Family of
Applicators Systems Block II
Subtotal III. Test and Evaluation:
0
200 1Q FY01
1162
0
1768
NONE
2667
Remarks:
Project DE4
Page 69 of 112 Pages
UNCLASSIFIED
Exhibit R-3 (PE 0603884BP)
UNCLASSIFIED
DATE
CBDP PROJECT COST ANALYSIS (R-3 Exhibit)
BUDGET ACTIVITY
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
IV. Management Services
JSFXD
PM/MS C - Joint IPT Support
JSSED
PM/MS S - JSSED - Service IPT
Support
SORBDECON
PM/MS S - Develop and Support
Milestone (MS) III Documentation
for Operator Spray Down Systems
ZSBIR
SBIR/STTR - Aggregated from
ZSBIR-SBIR/STTR
Subtotal IV. Management
Services:
February 2002
Contract
Method &
Type
Performing Activity &
Location
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
US
NF
CC
Total
PYs
Cost
FY2001
Cost
FY2001
Award
Date
MIPR
Various
U
0
918
Nov-00
MIPR
Various
U
0
1031 1Q FY01
MIPR
SBCCOM, APG, MD
U
1734
257 1Q FY01
PO
HQ AMC, Alexandria,
VA
U
0
0
1734
2206
NONE
FY2002
Cost
FY2002
Award
Date
341
Nov-01
500 1Q FY02
0
NONE
104 2Q FY02
945
FY2003
Cost
FY2003
Award
Date
0
NONE
848 1Q FY03
DE4
Cost to
Complete
Total
Cost
Target
Value of
Contract
0
1259
0
0
2379
0
0
NONE
0
1991
1834
0
NONE
0
104
0
0
5733
848
Remarks: SORBDECON - Milestone III included integration of the sorbent powder into an applicator; a market survey; testing of commercial applicators; and area coverage testing.
TOTAL PROJECT COST:
Project DE4
1734
3368
Page 70 of 112 Pages
UNCLASSIFIED
6143
6972
0
18217
Exhibit R-3 (PE 0603884BP)
UNCLASSIFIED
DATE
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2A Exhibit)
BUDGET ACTIVITY
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
COST (In Thousands)
HS4
February 2002
HOMELAND SECURITY (DEMVAL)
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
HS4
FY 2001
FY 2002
FY 2003
FY 2004
FY 2005
FY 2006
FY 2007
Cost to
Actual
Estimate
Estimate
Estimate
Estimate
Estimate
Estimate
Complete
0
0
55000
0
0
0
0
Total Cost
0
55000
A. Mission Description and Budget Item Justification:
Project HS4 HOMELAND SECURITY (DEMVAL): The Homeland Security System Development and Demonstration program is focused on
supporting a dual use operational capability for integrated biological surveillance, detection, and warning in the National Capital Region (NCR)
with technology insertions for improved performance and response. The biological surveillance system will be used to detect and alert to a
biological attack upon US urban assets, thus gaining time for an earlier, more informed public health and law enforcement response (e.g., start
treatment, secure hospital beds, etc.). This capability will be achieved primarily through the fusion of environmental sampling/sensors and
non-traditional detection using health, plant, and animal indicators. There are two approaches for early detection of a covert release of biological
warfare pathogens. The first uses sensors and environmental sampling to identify biological agents within minutes to several hours, depending on
the analysis processes used. The second approach consists of looking for early signs and symptoms of disease in human, animal, and plant
populations. The purpose of the program described here is to integrate the two approaches to obtain seamless early alerting benefits for military
and civilian populations in the area under surveillance.
FY 2001 Accomplishments: None
FY 2002 Planned Program: No planned program
Project HS4
Page 71 of 112 Pages
UNCLASSIFIED
Exhibit R-2 (PE 0603884BP)
UNCLASSIFIED
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2A Exhibit)
BUDGET ACTIVITY
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
DATE
February 2002
PE NUMBER AND TITLE
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
HS4
FY 2003 Planned Program:
6000 Homeland Security (Dev/Prod/Mgt) - Initiate system demonstration and testing of networked sensor ensemble to
include next generation camera assay reader.
·
·
4000 Homeland Security (Dev/Prod/Mgt) - Initiate system integration and demonstration of the next generation UV trigger
device for enhanced biological generic detection.
·
5000 Homeland Security (Dev/Prod/Mgt) - Demonstrate internal building surveillance using Mass Spectrometer chemical and
biological detection.
·
4000 Homeland Security (Dev/Prod/Mgt) - Demonstrate integration and testing of advanced aerosol collectors and an
automated dry filter collector concentrator.
·
8000 Homeland Security (Dev/Prod/Mgt) - Initiate system integration and demonstration of the JBPDS Block II upgrade
breadboard.
·
6500 Homeland Security (Dev/Prod/Mgt) - Initiate system integration and testing of UV standoff candidates for fixed site
protection.
·
·
·
·
·
·
1000 Homeland Security (Dev/Prod/Mgt) - Conduct ambient breeze tunnel (ABT) testing of systems and components.
Project HS4
1000 Homeland Security (Dev/Prod/Mgt) - Conduct background aerosol measurements and characterization.
1000 Homeland Security (Dev/Prod/Mgt) - Conduct indoor building flow characterization and testing.
1000 Homeland Security (Dev/Prod/Mgt) - Fabricate ABT for system and component testing.
3000 Homeland Security (Dev/Prod/Mgt) - Initiate systems engineering studies for deployment of sensors in the NCR.
1000 Homeland Security (Dev/Prod/Mgt) - Conduct wargames/tabletop exercises for CONOPS development.
Page 72 of 112 Pages
UNCLASSIFIED
Exhibit R-2 (PE 0603884BP)
UNCLASSIFIED
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2A Exhibit)
BUDGET ACTIVITY
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
DATE
February 2002
PE NUMBER AND TITLE
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
HS4
FY 2003 Planned Program (Cont):
3000 Homeland Security (Dev/Prod/Mgt) - Initiate system integration and development of an automated biological agent
testing system for laboratory analysis.
·
·
·
3000 Homeland Security (Dev/Prod/Mgt) - Initiate system development of core antibodies for ORIGEN and HHA devices.
·
3500 Homeland Security (Dev/Prod/Mgt) - Initiate system development of PCR reagents QA/QC and validation testing
protocols, and conduct downselect small scale fabrication and testing.
Total
4000 Homeland Security (Dev/Prod/Mgt) - Initiate system development and testing of improved reagent taggants (UCP,
Quantum, Fluorescent, Dentrimer) and multiplex assays and readers.
55000
B. Other Program Funding Summary: N/A
C. Acquisition Strategy: The Bio Surveillance system will be used to detect and alert to a biological attack upon US urban assets, thus
gaining time for an earlier, more informed public health and law enforcement response (e.g., start treatment, clear hospital beds, etc.). This
capability will be achieved primarily through the fusion of environmental sampling/sensors and non-traditional detection using health, plant,
and animal indicators. This program will utilize and leverage ongoing efforts in advanced development and existing procurement efforts,
executed by the Program Executive Office for Chemical and Biological Defense (PEOCBD) as well as promising technologies identified by
the Defense Threat Reduction Agency (DTRA) and the DoD Combating Terrorism Technology Task Force. The Chemical Biological
Defense Program will provide guidance and oversight to ensure a comprehensive and fully coordinated effort.
Project HS4
Page 73 of 112 Pages
UNCLASSIFIED
Exhibit R-2 (PE 0603884BP)
UNCLASSIFIED
DATE
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2A Exhibit)
BUDGET ACTIVITY
February 2002
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
D. Schedule Profile:
FY 2000
1
2
3
4
FY 2001
1
2
3
4
FY 2002
1
2
3
4
FY 2003
1
2
3
4
FY 2004
1
2
3
4
FY 2005
1
2
3
4
HS4
FY 2006
1
2
3
4
FY 2007
1
2
3
HLS
System Integration, Testing and
Demonstration of Bio Detection Systems
and Reagents
Project HS4
1Q
Page 74 of 112 Pages
UNCLASSIFIED
4Q
Exhibit R-2 (PE 0603884BP)
4
UNCLASSIFIED
DATE
CBDP PROJECT COST ANALYSIS (R-3 Exhibit)
BUDGET ACTIVITY
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
I. Product Development
HLS
HW C - Network Esembler
Contract
Method &
Type
MIPR
Performing Activity &
Location
NSWC - Dahlgren,
Dahlgren, VA
HW C - UV Trigger Upgrade
C/CPFF MIT Lincoln Lab,
Boston, MA
HW C - Mass Spectrometer
Internal Building Surveillance
C/CPFF TBS
HW C - Advanced Aerosol
Collectors demonstration
C/CPFF SENTEL Corp.,
Alexandria, VA & TBS
SW SB - ES - Systems
Engineering
SW SB - ES Studies Modeling
February 2002
MIPR
Institute for Defense
Analysis, Alexandria,
VA
C/CPFF Johns Hopkins Applied
Physics Laboratory,
Scaggsville, MD
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
US
NF
CC
Total
PYs
Cost
FY2001
Cost
FY2001
Award
Date
FY2002
Cost
FY2002
Award
Date
FY2003
Cost
FY2003
Award
Date
HS4
Cost to
Complete
Total
Cost
Target
Value of
Contract
U
0
0
NONE
0
NONE
6000 1Q FY03
0
6000
0
F
0
0
NONE
0
NONE
4000 1Q FY03
0
4000
0
0
0
NONE
0
NONE
5000
0
5000
0
C
0
0
NONE
0
NONE
4000 1Q FY03
0
4000
0
F
0
0
NONE
0
NONE
1000 2Q FY03
0
1000
0
F
0
0
NONE
0
NONE
2000 1Q FY03
0
2000
0
NONE
HW S - Ambient Breeze Tunnel
Construction
C/FFP
BATTELLE, Columbus,
OH
N
0
0
NONE
0
NONE
1000 2Q FY03
0
1000
0
HW C - Background Aerosol
Measurements
MIPR
TBS
U
0
0
NONE
0
NONE
1000 1Q FY03
0
1000
0
HW C - Indoor Building flow
Characterization
MIPR
TBS
U
0
0
NONE
0
NONE
1000 1Q FY03
0
1000
0
HW C - UV Standoff/Fixed Site
C/CPFF TBS
C
0
0
NONE
0
NONE
6000 2Q FY03
0
6000
0
HW C - JBPDS Block II
C/CPFF TBS
C
0
0
NONE
0
NONE
6500 2Q FY03
0
6500
0
Project HS4
Page 75 of 112 Pages
UNCLASSIFIED
Exhibit R-3 (PE 0603884BP)
UNCLASSIFIED
DATE
CBDP PROJECT COST ANALYSIS (R-3 Exhibit)
BUDGET ACTIVITY
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
I. Product Development - Cont.
February 2002
Contract
Method &
Type
Performing Activity &
Location
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
US
NF
CC
Total
PYs
Cost
FY2001
Cost
FY2001
Award
Date
FY2002
Cost
FY2002
Award
Date
FY2003
Cost
FY2003
Award
Date
HS4
Cost to
Complete
Total
Cost
Target
Value of
Contract
HW C - Automated Bio Testing
System
MIPR
SBCCOM, Edgewood,
MD
U
0
0
NONE
0
NONE
3000 1Q FY03
0
3000
0
HW C - Critical Reagent
Development
MIPR
USAMRIID, Frederick,
MD
U
0
0
NONE
0
NONE
3000 1Q FY03
0
3000
0
C
0
0
NONE
0
NONE
4000 2Q FY03
0
4000
0
U
0
0
NONE
0
NONE
3500 2Q FY03
0
3500
0
0
0
0
51000
HW C - Reagent
Taggants/Multiplex
HW C - PCR Reagents and
Protocols
C/CPFF TBS
MIPR
TBS
Subtotal I. Product Development:
0
51000
Remarks:
II. Support Costs
HLS
TD/D C - Wargaming/Tabletop
CONOPS Development
Subtotal II. Support Costs:
Contract
Method &
Type
Performing Activity &
Location
C/CPFF TBS
US
NF
CC
C
Total
PYs
Cost
FY2001
Cost
FY2001
Award
Date
0
0
0
0
NONE
FY2002
Cost
FY2002
Award
Date
0
0
NONE
FY2003
Cost
FY2003
Award
Date
Cost to
Complete
Total
Cost
Target
Value of
Contract
1000 2Q FY03
0
1000
1000
0
1000
Remarks:
Project HS4
Page 76 of 112 Pages
UNCLASSIFIED
Exhibit R-3 (PE 0603884BP)
0
UNCLASSIFIED
DATE
CBDP PROJECT COST ANALYSIS (R-3 Exhibit)
BUDGET ACTIVITY
February 2002
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
HS4
III. Test and Evaluation: Not applicable
IV. Management Services
HLS
PM/MS C - PEOCBD Program
Management Support
Subtotal IV. Management
Services:
Contract
Method &
Type
Allot
Performing Activity &
Location
PEOCBD, Falls Church,
VA
US
NF
CC
U
Total
PYs
Cost
FY2001
Cost
FY2001
Award
Date
0
0
0
0
0
0
NONE
FY2002
Cost
FY2002
Award
Date
0
NONE
FY2003
Cost
FY2003
Award
Date
Cost to
Complete
Total
Cost
Target
Value of
Contract
3000 1Q FY03
0
3000
0
3000
0
3000
0
55000
0
55000
Remarks:
TOTAL PROJECT COST:
Project HS4
Page 77 of 112 Pages
UNCLASSIFIED
Exhibit R-3 (PE 0603884BP)
0
UNCLASSIFIED
DATE
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2A Exhibit)
BUDGET ACTIVITY
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
COST (In Thousands)
IP4
February 2002
INDIVIDUAL PROTECTION (DEMVAL)
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
IP4
FY 2001
FY 2002
FY 2003
FY 2004
FY 2005
FY 2006
FY 2007
Cost to
Actual
Estimate
Estimate
Estimate
Estimate
Estimate
Estimate
Complete
16610
14317
0
0
0
0
0
Total Cost
0
30927
A. Mission Description and Budget Item Justification:
Project IP4 INDIVIDUAL PROTECTION (DEMVAL):
This project funds System Acquisition of individual protection equipment aimed at improving current protection levels while reducing
physiological and logistical burdens. The goal is to provide equipment that allows the individual soldier, sailor, airman, or marine to operate in a
contaminated chemical and biological (CB) environment with no or minimal degradation to his/her performance. This project includes the Joint
Service General Purpose Mask (JSGPM) and the Joint Service Aircrew Mask (JSAM). The JSGPM will reduce weight, bulk, and breathing
resistance by as much as 50 percent over previously fielded masks. The JSGPM will also improve vision coupling, communication effectiveness,
and comfort/wearability. The mask will significantly reduce total ownership cost/life cycle cost. The JSGPM will be low maintenance and priced
to be classified as disposable/replaceable after decontamination. JSAM will provide rotary and fixed wing aircrew members with
above-the-shoulder CB protection and, when integrated with a Pressure Breathing for G system, will provide anti-G protection in high
performance aircraft. JSAM will integrate with existing aircrew life support systems equipment and support equipment.
Project IP4
Page 78 of 112 Pages
UNCLASSIFIED
Exhibit R-2 (PE 0603884BP)
UNCLASSIFIED
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2A Exhibit)
BUDGET ACTIVITY
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
DATE
February 2002
PE NUMBER AND TITLE
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
IP4
FY 2001 Accomplishments:
5422 JSAM - Continued design, initial development, and contractor sub-system qualification testing in preparation for
prototype fabrication.
·
·
1452 JSAM - Continued risk reduction/system engineering/Cost As an Independent Variable (CAIV) analysis
studies/program management activities.
·
888 JSAM - Continued government test working group activities. The government test team conducted 13 Test Planning
Working Group meetings to draft plans and procedures for Program Definition/Risk Reduction (PDRR) prototype
testing.
·
1201 JSGPM - Continued preparation for Interim Progress Review and transitioned to the System Demonstration acquisition
phase. These activities included finalization of the Single Acquisition Management Plan (SAMP), Test and Evaluation
Master Plan (TEMP), and the Manpower and Personnel Integration (MANPRINT) Plan.
·
6245 JSGPM - Continued Program Definition and Risk Reduction contract for mask design and 800 prototypes at $1500
each. Contractor initiated design of mask to Joint Service performance specifications with Joint Service input.
·
1142 JSGPM - Conducted Engineering Design Test (EDT) planning. Testing ensured meeting Joint Service requirements for
protection, communication, drinking, breathing resistance, and weight/bulk limitations.
·
Total
Project IP4
260 JSGPM - Continued sustainment study for logistics support.
16610
Page 79 of 112 Pages
UNCLASSIFIED
Exhibit R-2 (PE 0603884BP)
UNCLASSIFIED
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2A Exhibit)
BUDGET ACTIVITY
DATE
February 2002
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
IP4
FY 2002 Planned Program:
3317 JSAM - Completed PDRR test plans/procedures. The Government will evaluate the prototypes for chemical agent
permeation, fit factor, positive pressure breathing for altitude, anti-G endurance (centrifuge), air crew life support
equipment integration and aircraft interface checks, human factors and environmental factors. Initiate test planning for
system demonstration phase.
·
·
4452 JSAM - Completed contractor qualification test and fabricated prototypes (25 of each variant). Total number of
variants and cost per prototype is competition sensitive information. Delivered prototypes to the government for PDRR
testing on 30 Jan 2002.
·
1858 JSAM - Continue system engineering and program management activities and support government PDRR prototype
testing. Prepare for MS B Interim Progress Review (IPR) and transition to System Demonstration.
·
739 JSGPM - Complete preparation for Interim Progress Review and transition to the System Demonstration acquisition
phase. These activities will include finalization of the Single Acquisition Management Plan (SAMP), Test and
Evaluation Master Plan (TEMP), and the Manpower and Personnel Integration (MANPRINT) Plan.
·
1500 JSGPM - Complete Program Definition and Risk Reduction contract for mask design and 800 prototypes at $1500
each. Contractor will design mask to Joint Service performance specifications with Joint Service input.
·
2008 JSGPM - Conduct Engineering Design Test (EDT). Testing ensures meeting Joint Service requirements for protection,
communication, drinking, breathing resistance, and weight/bulk limitations.
·
·
Total
Project IP4
200 JSGPM - Continue sustainment study for logistics support.
243 SBIR - Small Business Innovative Research.
14317
Page 80 of 112 Pages
UNCLASSIFIED
Exhibit R-2 (PE 0603884BP)
UNCLASSIFIED
DATE
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2A Exhibit)
BUDGET ACTIVITY
February 2002
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
IP4
FY 2003 Planned Program: No planned program
B. Other Program Funding Summary:
To
Compl
Total
Cost
FY 2001
FY 2002
FY 2003
FY 2004
FY 2005
FY 2006
FY 2007
8288
20711
39044
36195
12735
1411
0
JA0002 JT SVC AVIATION MASK (JSAM)
0
0
0
0
0
10970
10971
Cont
Cont
JA0003 JOINT SERVICE GENERAL PURPOSE
MASK (JSGPM)
0
0
0
0
15735
25518
34802
Cont
Cont
JN0011 AERP AIRCRAFT MODS
1574
2941
896
0
0
0
0
0
5411
JN0013 NAVY INDIVIDUAL PROTECTIVE GEAR
5379
2312
3186
0
0
0
0
0
10877
0
0
11859
4963
4931
4938
4933
Cont
Cont
4124
993
0
0
0
0
0
0
5117
998
454
0
0
0
0
0
0
1452
1485
142
0
0
0
0
0
0
1627
IP5 INDIVIDUAL PROTECTION (EMD)
JSM001 JOINT SERVICE MASK LEAKAGE
TESTER (JSMLT)
JX0055 INDIVIDUAL PROTECTION (IP) ITEMS
LESS THAN $5M
M99501 MASK, AIRCRAFT M45
M99601 MASK, CHEM-BIOLOGICAL
PROTECTIVE FIELD: M40/M40A
Project IP4
Page 81 of 112 Pages
UNCLASSIFIED
0 118384
Exhibit R-2 (PE 0603884BP)
UNCLASSIFIED
DATE
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2A Exhibit)
BUDGET ACTIVITY
February 2002
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
IP4
B. Other Program Funding Summary (Cont):
MA0400 PROTECTIVE CLOTHING
MA0480 SECOND SKIN, MASK MCU-2/P
FY 2001
FY 2002
FY 2003
FY 2004
FY 2005
FY 2006
FY 2007
To
Compl
Total
Cost
96991
98531
91202
79913
89460
99584
92179
Cont
Cont
918
3447
13183
0
0
0
0
0
17548
C. Acquisition Strategy:
JSGPM
The Acquisition Strategy requires a combined full-scale development and production contract including contractor
logistics support (Program Definition and Risk Reduction, Engineering and Manufacturing Development, and
Production). The development/production contract is based on a Joint Service performance specification with special
emphasis on reducing weight, bulk, and breathing resistance by as much as 50 percent over current fielded protective
masks, and lowest achievable total ownership cost.
JSAM
Acquisition strategy is to award dual contracts for PDRR with a full and open downselect to one contractor for System
Demonstration with production options. Implementation of Cost As An Independent Variable (CAIV) is crucial to the
PDRR phase with special emphasis on reducing Life Cycle Cost. JSAM prototypes tested during PDRR will be available
to the JPACE program in Oct 02 for physical integration checks.
Project IP4
Page 82 of 112 Pages
UNCLASSIFIED
Exhibit R-2 (PE 0603884BP)
UNCLASSIFIED
DATE
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2A Exhibit)
BUDGET ACTIVITY
February 2002
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
D. Schedule Profile:
FY 2000
1
2
3
4
FY 2001
1
2
3
4
FY 2002
1
2
3
4
FY 2003
1
2
3
4
FY 2004
1
2
3
4
FY 2005
1
2
3
4
IP4
FY 2006
1
2
3
4
FY 2007
1
2
3
JSAM
Milestone I
2Q
Program Definition and Risk Reduction
(PDRR)
4Q
4Q
Program Definition and Risk Reduction
(PDRR) Prototype Fabrication/Delivery
4Q
2Q
Program Definition and Risk Reduction
(PDRR) Prototype Government Test
2Q 3Q
Milestone B In Process Review (IPR) (IP5)
3Q
JSGPM
Test Evaluation Master Plan (TEMP)
Approved
Development Contract Award
Engineering Design Test (EDT) Planning
>>
1Q
2Q
1Q
4Q
Engineering Design Test (EDT)
1Q
First Prototype
1Q
Interim Progress Review (IPR) for
Transition to Systems Demonstration Phase
Project IP4
2Q
Page 83 of 112 Pages
UNCLASSIFIED
Exhibit R-2 (PE 0603884BP)
4
UNCLASSIFIED
DATE
CBDP PROJECT COST ANALYSIS (R-3 Exhibit)
BUDGET ACTIVITY
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
I. Product Development
Contract
Method &
Type
Performing Activity &
Location
JSAM
HW S - JSAM Initial Development C/CPFF SAIC, Abingdon, MD
SW S - JWARN SDD Contract
JSGPM
SW SB - PDRR Contract for Mask
Design and 800 Prototypes
Subtotal I. Product Development:
February 2002
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
US
NF
CC
Total
PYs
Cost
FY2001
Cost
FY2001
Award
Date
FY2002
Cost
FY2002
Award
Date
FY2003
Cost
FY2003
Award
Date
IP4
Cost to
Complete
Total
Cost
Target
Value of
Contract
C
1659
2494 1Q FY01
2463 1Q FY02
0
NONE
0
6616
0
C/CPFF Gentex Corp., Rancho
Cucamonga, CA
C
1659
2731 1Q FY01
1989 1Q FY02
0
NONE
0
6379
0
C/CPFF Avon Inc., Cadillac, MI
C
3800
5466
1500 1Q FY02
0
NONE
0
10766
9300
7118
10691
5952
0
0
23761
Feb-01
Remarks:
Project IP4
Page 84 of 112 Pages
UNCLASSIFIED
Exhibit R-3 (PE 0603884BP)
UNCLASSIFIED
DATE
CBDP PROJECT COST ANALYSIS (R-3 Exhibit)
BUDGET ACTIVITY
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
II. Support Costs
JSAM
ILS S - JSAM - Supportability
Analysis
ILS S - Supportability Analysis
JSGPM
ILS S - Conduct Sustainment
Study for Prime Vendor Delivery
and Contractor Logistics Support
TD/D S - Conduct Program/Project
Documentation
Subtotal II. Support Costs:
February 2002
Contract
Method &
Type
Performing Activity &
Location
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
US
NF
CC
Total
PYs
Cost
FY2001
Cost
C/CPFF SAIC, Abingdon, MD
C
0
C/CPFF Gentex Corp., Rancho
Cucamonga, CA
C
0
FY2001
Award
Date
98 1Q FY01
100
NONE
FY2002
Cost
FY2002
Award
Date
FY2003
Cost
FY2003
Award
Date
IP4
Cost to
Complete
Total
Cost
Target
Value of
Contract
0
NONE
0
NONE
0
98
0
0
NONE
0
NONE
0
100
0
PO
PM NBCDS, APG, MD
U
240
260 1Q FY01
200 1Q FY02
0
NONE
0
700
640
PO
PM NBCDS, APG, MD
U
600
968 1Q FY01
500 1Q FY02
0
NONE
0
2068
1600
700
0
0
2966
840
1426
Remarks:
Project IP4
Page 85 of 112 Pages
UNCLASSIFIED
Exhibit R-3 (PE 0603884BP)
UNCLASSIFIED
DATE
CBDP PROJECT COST ANALYSIS (R-3 Exhibit)
BUDGET ACTIVITY
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
III. Test and Evaluation
JSAM
DTE S - Govt Test Activities
JSGPM
OTHT SB - Conduct Engineering
Design Test (EDT) planning
Subtotal III. Test and Evaluation:
February 2002
Contract
Method &
Type
Performing Activity &
Location
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
US
NF
CC
Total
PYs
Cost
FY2001
Cost
FY2001
Award
Date
FY2002
Cost
FY2002
Award
Date
FY2003
Cost
FY2003
Award
Date
IP4
Cost to
Complete
Total
Cost
Target
Value of
Contract
PO
NAVAIR (Patuxent
River, MD) & AFOTEC
(Kirtland AFB, NM)
U
120
888 1Q FY01
3317 1Q FY02
0
NONE
0
4325
0
Various
DTC, APG, MD; HRED,
APG, MD
U
500
1006 1Q FY01
2008 1Q FY02
0
NONE
0
3514
0
620
1894
5325
0
0
7839
Remarks:
Project IP4
Page 86 of 112 Pages
UNCLASSIFIED
Exhibit R-3 (PE 0603884BP)
UNCLASSIFIED
DATE
CBDP PROJECT COST ANALYSIS (R-3 Exhibit)
BUDGET ACTIVITY
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
IV. Management Services
JSAM
PM/MS S - Mission Support
February 2002
Contract
Method &
Type
MIPR
Performing Activity &
Location
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
US
NF
CC
Total
PYs
Cost
FY2001
Cost
FY2001
Award
Date
FY2002
Cost
FY2002
Award
Date
FY2003
Cost
FY2003
Award
Date
IP4
Cost to
Complete
Total
Cost
Target
Value of
Contract
Various
U
1086
1451 1Q FY01
1858 1Q FY02
0
NONE
0
4395
0
1148 1Q FY01
239 1Q FY02
0
NONE
0
2647
2360
243 2Q FY02
0
NONE
0
243
0
JSGPM
PM/MS S - Conducted Joint
Program/Project Management
PO
PM NBCDS, APG, MD
U
1260
ZSBIR
SBIR/STTR - Aggregated from
ZSBIR-SBIR/STTR
PO
HQ AMC, Alexandria,
VA
U
0
0
2346
2599
2340
0
0
7285
10924
16610
14317
0
0
41851
Subtotal IV. Management
Services:
NONE
Remarks:
TOTAL PROJECT COST:
Project IP4
Page 87 of 112 Pages
UNCLASSIFIED
Exhibit R-3 (PE 0603884BP)
UNCLASSIFIED
DATE
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2A Exhibit)
BUDGET ACTIVITY
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
COST (In Thousands)
MB4
February 2002
MEDICAL BIOLOGICAL DEFENSE (DEMVAL)
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
MB4
FY 2001
FY 2002
FY 2003
FY 2004
FY 2005
FY 2006
FY 2007
Cost to
Actual
Estimate
Estimate
Estimate
Estimate
Estimate
Estimate
Complete
28465
34343
42617
46775
10271
14874
Total Cost
12361 Continuing Continuing
A. Mission Description and Budget Item Justification:
Project MB4 MEDICAL BIOLOGICAL DEFENSE (DEMVAL): This project funds advanced development including Component Advanced
Development (CAD) and Systems Development and Demonstration (SDD) for vaccines, drugs, and diagnostic medical devices that are directed
against validated biological warfare (BW) agents to include bacteria, viruses, and toxins of biological origin. This project also funds special
studies to develop, test, and evaluate novel vaccine formulations to reduce or eliminate "shots" and to protect U.S. forces from BW agents.
Efforts for medical biological defense product development include establishing standards and reference material for manufacturing and
preliminary safety studies in animals. This data (manufacturing process development, pilot lot manufacturing, and non-clinical safety/toxicology
studies) are submitted in support of an Investigational New Drug (IND) application with the Food and Drug Administration (FDA) so that human
studies to evaluate product safety and immunogenicity can be conducted. Advanced development efforts are expected to be accomplished within
four years. At the end of SDD, the product will transition to the Production and Deployment phase. Products being developed under this
program include: Recombinant Botulinum, Next Generation Anthrax, Plague, Smallpox, Tularemia, Staphylococcal Enterotoxins, and Equine
Encephalitis vaccines.
Project MB4
Page 88 of 112 Pages
UNCLASSIFIED
Exhibit R-2 (PE 0603884BP)
UNCLASSIFIED
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2A Exhibit)
BUDGET ACTIVITY
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
DATE
February 2002
PE NUMBER AND TITLE
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
MB4
FY 2001 Accomplishments:
9372 JVAP - Tularemia Vaccine - Continued manufacturing process development for Tularemia vaccine including
formulation studies. Conducted development and validation of assays for virulence and potency. Began development of
efficacy testing method in animals.
·
·
10288 JVAP - Recombinant Botulinum Vaccine - Continued manufacturing process development and purification refinement
of Botulinum vaccines. Prepared master and working seed banks. Began preparation for manufacture of current Good
Manufacturing Practices (cGMP) pilot lots.
·
2807 JVAP - Equine Encephalitis Vaccines - Completed pilot lot manufacture. Conducted stability and formulation studies
and performed assay development and validation for Venezuelan Equine Encephalitis (VEE) 1A vaccine.
·
1622 JVAP - Smallpox Vaccine - Submitted IND application and executed clinical trial for Vaccinia Immune Globulin
(VIG). Initiated assay development for Smallpox vaccine. Conducted clinical trial for smallpox vaccine licensure
studies.
·
2932 JVAP - Plague Vaccine - Continued component advanced development for a manufacturing process for combined F1+V
Plague vaccine candidate.
·
400 JVAP - Next Generation Anthrax Vaccine (NGAV) - Initiated technology transfer and process definition for a candidate
recombinant protective antigen NGAV.
·
1044 JVAP - Vaccine component advanced development - Initiated development of novel antigens (Ricin, Staphylococcal
Enterotoxins), adjuvants, preservatives, and delivery systems for biological defense vaccines. This included formulation
and process development studies; preclinical; initial safety and immunogenicity studies; and supported technology
transfer from the research laboratories.
Total
28465
Project MB4
Page 89 of 112 Pages
UNCLASSIFIED
Exhibit R-2 (PE 0603884BP)
UNCLASSIFIED
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2A Exhibit)
BUDGET ACTIVITY
DATE
February 2002
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
MB4
FY 2002 Planned Program:
10230 JVAP - Tularemia Vaccine - Continue efficacy testing and begin immunogenicity, toxicity, and potency studies for
Tularemia vaccine. Begin pilot lot manufacturing and stability testing. Conduct pre-IND meeting with FDA.
·
·
11951 JVAP - Recombinant Botulinum Vaccine - Continue manufacturing process refinement studies, including antigen and
adjuvant characterization for both serotypes of the recombinant Botulinum vaccine. Begin pilot lot production of
individual serotypes and conduct non-clinical testing of multivalent Recombinant Botulinum vaccine.
·
2590 JVAP - Equine Encephalitis Vaccines - Conduct process development and safety studies for Venezuelan Equine
Encephalitis (VEE) 1A component of the vaccine.
·
5105 JVAP - Plague Vaccine - Conduct process development and conduct comparability studies in higher animal species for
Plague vaccine. Initiate assay development and validation.
·
3500 JVAP - Next Generation Anthrax Vaccine - Conduct process definition studies of candidate recombinant protective
antigen NGAV including stability and formulation studies.
·
386 JVAP - Vaccine component advanced development - Continue development of novel antigens (Staphylococcal
Enterotoxins, Ricin), adjuvants, preservatives, and delivery systems for biological defense vaccines. This includes
formulation and process development studies; preclinical; initial safety and immunogenicity studies; and supports
technology transfer from the research laboratories.
·
581 SBIR - Small Business Innovative Research.
Total
34343
Project MB4
Page 90 of 112 Pages
UNCLASSIFIED
Exhibit R-2 (PE 0603884BP)
UNCLASSIFIED
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2A Exhibit)
BUDGET ACTIVITY
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
DATE
February 2002
PE NUMBER AND TITLE
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
MB4
FY 2003 Planned Program:
4684 JVAP - Recombinant Botulinum Vaccine - Continue manufacturing process development and begin process validation
for recombinant Botulinum vaccine. Continue manufacturing pilot lots of serotypes A and B.
·
·
·
·
5149 JVAP - Recombinant Botulinum Vaccine - Begin bulk stability and final container stability testing of pilot lot.
2671 JVAP - Recombinant Botulinum Vaccine - Begin single serotype phase 1 clinical trial preparation.
6688 JVAP - Equine Encephalitis Vaccines - Continue assay development and validation. Continue process optimization
including demonstration runs. Begin process validation and pilot lot manufacturing for VEE IE component.
·
3620 JVAP - Equine Encephalitis Vaccines - Begin efficacy testing and continue bulk stability testing. Begin container
stability testing. Conduct higher animal species testing and equine safety study.
·
1592 JVAP - Next Generation Anthrax Vaccine - Complete process definition work for a candidate recombinant protective
antigen NGAV. Manufacture and characterize master seed and working seed banks. Conduct assay development and
validation.
·
4614 JVAP - Plague Vaccine - Manufacture and characterize master seed and working seed banks. Continue assay
development and validation.
·
·
1646 JVAP - Plague Vaccine - Complete process development work and conduct pilot lot manufacturing.
·
·
2965 JVAP - Tularemia Vaccine - Complete characterization studies and surrogate marker of efficacy assay.
Project MB4
1756 JVAP - Plague Vaccine - Begin process toxicity testing and immunogenicity studies. Begin bulk stability, container
stability, and reconstitution stability testing. Conduct pre-IND preparation.
6660 JVAP - Tularemia Vaccine - Begin Phase I clinical trial execution and monitoring.
Page 91 of 112 Pages
UNCLASSIFIED
Exhibit R-2 (PE 0603884BP)
UNCLASSIFIED
DATE
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2A Exhibit)
BUDGET ACTIVITY
February 2002
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
MB4
FY 2003 Planned Program (Cont):
572 JVAP - Tularemia Vaccine - Conduct bulk stability and final container stability testing of pilot lot. Prepare and submit
IND application to FDA.
·
Total
42617
B. Other Program Funding Summary:
FY 2001
FY 2002
FY 2003
FY 2004
FY 2005
FY 2006
FY 2007
To
Compl
Total
Cost
JX0005 DOD BIOLOGICAL VACCINE
PROCUREMENT
50629
55684
43695
57626
62250
58108
58841
Cont
Cont
MB5 MEDICAL BIOLOGICAL DEFENSE (EMD)
15772
48500
44718
20284
35904
36056
39815
Cont
Cont
C. Acquisition Strategy:
JVAP
Project MB4
The Prime Systems Contract (PSC) serves as the integrator for the advanced development, licensure, production, storage,
testing, and distribution of medical biological defense vaccines and antisera. The PSC serves as the "responsible head" to
the Food and Drug Administration for each product during the licensure process and becomes the license holder for the
product. The JVAP oversees the PSC.
Page 92 of 112 Pages
UNCLASSIFIED
Exhibit R-2 (PE 0603884BP)
UNCLASSIFIED
DATE
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2A Exhibit)
BUDGET ACTIVITY
February 2002
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
D. Schedule Profile:
FY 2000
1
2
3
4
FY 2001
1
2
3
4
FY 2002
1
2
3
4
FY 2003
1
2
3
4
FY 2004
1
2
3
4
FY 2005
1
2
3
4
MB4
FY 2006
1
2
3
4
FY 2007
1
2
3
4
VAC BOT
Process Development
3Q
3Q
cGMP Pilot Lot
2Q
Non-Clinical Testing
2Q
4Q
4Q
Investigational New Drug (IND)
Application Submission
2Q
Phase 1 Clinical Trial (A/B)
2Q
4Q
Phase 2a Clinical Trial
3Q
4Q
VAC ENC
Process Development
cGMP Pilot Lots
3Q
4Q
3Q
1Q
Non-Clinical Testing
1Q
3Q
Investigational New Drug (IND)
Application
4Q
Phase 1 Clinical Trials
1Q
4Q
VAC NGA
Process Development
2Q
cGMP Pilot Lot
Non-Clinical Testing
Project MB4
2Q
3Q
1Q
4Q
Page 93 of 112 Pages
UNCLASSIFIED
4Q
Exhibit R-2 (PE 0603884BP)
UNCLASSIFIED
DATE
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2A Exhibit)
BUDGET ACTIVITY
February 2002
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
D. Schedule Profile (cont):
FY 2000
1
2
3
4
FY 2001
1
2
3
4
FY 2002
1
2
3
4
FY 2003
1
2
3
4
FY 2004
1
2
3
4
FY 2005
1
2
3
4
MB4
FY 2006
1
2
3
4
FY 2007
1
2
3
4
VAC NGA (Cont)
Investigational New Drug (IND)
Application
4Q
Milestone C
4Q
Phase 2a Clinical Trial
2Q
2Q
Milestone C
3Q
4Q
VAC PLG
Process Development
2Q
1Q
cGMP Pilot Lot
2Q
Non-Clinical Testing
2Q
Investigational New Drug (IND)
Application Submission
4Q
4Q
4Q
Phase 1 Clinical Trial
4Q
2Q 3Q
Phase 2a Clinical Trial
4Q
Milestone C
4Q
1Q
VAC SPX
Process Development
Phase 2a Clinical Trial
cGMP Pilot Lot
Project MB4
3Q
1Q
1Q
3Q
4Q 1Q
Page 94 of 112 Pages
UNCLASSIFIED
Exhibit R-2 (PE 0603884BP)
4Q
UNCLASSIFIED
DATE
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2A Exhibit)
BUDGET ACTIVITY
February 2002
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
D. Schedule Profile (cont):
FY 2000
1
2
3
4
FY 2001
1
2
3
4
FY 2002
1
2
3
4
FY 2003
1
2
3
4
FY 2004
1
2
3
4
FY 2005
1
2
3
4
MB4
FY 2006
1
2
3
4
FY 2007
1
2
3
VAC SPX (Cont)
Non-Clinical Testing
3Q
Investigational New Drug (IND)
Application Submission
3Q
2Q
Milestone C
1Q
VAC TUL
Process Development
cGMP Pilot Lot
>>
2Q
3Q 4Q
Investigational New Drug (IND)
Application Submission
2Q
Phase 1 Clinical Trial
3Q 4Q
Phase 2a Clinical Trial
1Q
Milestone C
Project MB4
1Q
2Q
Page 95 of 112 Pages
UNCLASSIFIED
Exhibit R-2 (PE 0603884BP)
4
UNCLASSIFIED
DATE
CBDP PROJECT COST ANALYSIS (R-3 Exhibit)
BUDGET ACTIVITY
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
I. Product Development
February 2002
Contract
Method &
Type
Performing Activity &
Location
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
US
NF
CC
Total
PYs
Cost
FY2001
Cost
FY2001
Award
Date
FY2002
Cost
FY2002
Award
Date
FY2003
Cost
FY2003
Award
Date
MB4
Cost to
Complete
Total
Cost
Target
Value of
Contract
VAC BOT
HW S - Vaccine Development Includes Consistency Lot, Pilot
Lot, and scale-up Production.
C/CPAF DynPort Vaccine
Company, Frederick,
MD
C
0
0
NONE
0
NONE
2813
Nov-02
0
2813
0
VAC ENC
HW S - Vaccine Development Includes consistency lot, pilot lot,
and scale-up production.
C/CPAF DynPort Vaccine
Company, Frederick,
MD
C
0
0
NONE
0
NONE
3918
Nov-02
0
3918
0
C
0
0
NONE
0
NONE
1324
Nov-02
0
1324
0
VAC NGA
C/CPAF DynPort Vaccine
HW S - Vaccine Development Company, Frederick,
Includes consistency Lot, Pilot Lot,
and scale-up Production.
MD
VAC PLG
HW S - Vaccine Development Includes Consistency Lot, Pilot
Lot, and Scale-up Production.
C/CPAF DynPort Vaccine
Company, Frederick,
MD
C
0
0
NONE
0
NONE
3642
Nov-02
0
3642
0
VAC TUL
HW S - Vaccine Development Includes Consistency Lot, Pilot
Lot, and Scale-up Production.
C/CPAF DynPort Vaccine
Company, Frederick,
MD
C
0
0
NONE
0
NONE
1737
Nov-02
0
1737
0
VACCINES
HW S - Vaccine Development Includes Consistency Lot, Pilot
Lot, and Scale-up Production.
C/CPAF DynPort Vaccine
Company, Frederick,
MD
C
5536
9371
Nov-00
10987
Nov-01
0
NONE
0
25894
0
5536
9371
0
39328
Subtotal I. Product Development:
Project MB4
Page 96 of 112 Pages
UNCLASSIFIED
10987
13434
Exhibit R-3 (PE 0603884BP)
UNCLASSIFIED
DATE
CBDP PROJECT COST ANALYSIS (R-3 Exhibit)
BUDGET ACTIVITY
February 2002
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
MB4
I. Product Development - Cont.
Remarks: Cost to Complete: "Continuing"
II. Support Costs
VAC BOT
TD/D S - Vaccine Development Includes Regulatory Integration
(Environmental and FDA
Documentation) and Delivery
System.
VAC NGA
TD/D S - Vaccine Development Includes Regulatory Integration
(Environmental and FDA
Documentation) and delivery
System.
VAC PLG
TD/D S - Vaccine Development Includes Regulatory Integration
(Environmental and FDA
Documentation) and Delivery
System.
Project MB4
Contract
Method &
Type
Performing Activity &
Location
US
NF
CC
Total
PYs
Cost
FY2001
Cost
FY2001
Award
Date
FY2002
Cost
FY2002
Award
Date
FY2003
Cost
FY2003
Award
Date
Cost to
Complete
Total
Cost
Target
Value of
Contract
C/CPAF DynPort Vaccine
Company, Frederick,
MD
C
0
0
NONE
0
NONE
123
Nov-02
0
123
0
C/CPAF DynPort Vaccine
Company, Frederick,
MD
C
0
0
NONE
0
NONE
42
Nov-02
0
42
0
C/CPAF DynPort Vaccine
Company, Frederick,
MD
C
0
0
NONE
0
NONE
64
Nov-02
0
64
0
Page 97 of 112 Pages
UNCLASSIFIED
Exhibit R-3 (PE 0603884BP)
UNCLASSIFIED
DATE
CBDP PROJECT COST ANALYSIS (R-3 Exhibit)
BUDGET ACTIVITY
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
II. Support Costs - Cont.
VAC TUL
TD/D S - Vaccine Development Includes Regulatory Integration
(Environmental and FDA
Documentation) and Delivery
System.
VACCINES
TD/D S - Vaccine Development Includes Regulatory Integration
(Environmental and FDA
Documentation) and Delivery
System.
February 2002
Contract
Method &
Type
Performing Activity &
Location
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
US
NF
CC
Total
PYs
Cost
FY2001
Cost
FY2001
Award
Date
FY2002
Cost
FY2002
Award
Date
FY2003
Cost
FY2003
Award
Date
MB4
Cost to
Complete
Total
Cost
Target
Value of
Contract
C/CPAF DynPort Vaccine
Company, Frederick,
MD
C
0
0
NONE
0
NONE
163
Nov-02
0
163
0
C/CPAF DynPort Vaccine
Company, Frederick,
MD
C
2689
4551
Nov-00
5532
Nov-01
0
NONE
0
12772
0
2689
4551
0
13164
Subtotal II. Support Costs:
5532
392
Remarks: Cost to Complete: "Continuing"
Project MB4
Page 98 of 112 Pages
UNCLASSIFIED
Exhibit R-3 (PE 0603884BP)
UNCLASSIFIED
DATE
CBDP PROJECT COST ANALYSIS (R-3 Exhibit)
BUDGET ACTIVITY
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
III. Test and Evaluation
February 2002
Contract
Method &
Type
Performing Activity &
Location
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
US
NF
CC
Total
PYs
Cost
FY2001
Cost
FY2001
Award
Date
FY2002
Cost
FY2002
Award
Date
FY2003
Cost
FY2003
Award
Date
MB4
Cost to
Complete
Total
Cost
Target
Value of
Contract
VAC BOT
DTE S - Vaccine Development Includes Testing, Evaluation, and
Clinical Trials.
C/CPAF DynPort Vaccine
Company, Frederick,
MD
C
0
0
NONE
0
NONE
5174
Nov-02
0
5174
0
VAC ENC
DTE S - Vaccine Development Testing, Evaluation, and Clinical
Trials.
C/CPAF DynPort Vaccine
Company, Frederick,
MD
C
0
0
NONE
0
NONE
2869
Nov-02
0
2869
0
C/CPAF DynPort Vaccine
Company, Frederick,
MD
C
0
0
NONE
0
NONE
26
Nov-02
0
26
0
VAC PLG
DTE S - Vaccine Development Testing, Evaluation, and Clinical
Trials.
C/CPAF DynPort Vaccine
Company, Frederick,
MD
C
0
0
NONE
0
NONE
1564
Nov-02
0
1564
0
VAC TUL
DTE S - Vaccine Development Testing, Evaluation, and Clinical
Trials.
C/CPAF DynPort Vaccine
Company, Frederick,
MD
C
0
0
NONE
0
NONE
4813
Nov-02
0
4813
0
VAC NGA
DTE S - Vaccine Development Includes Clinical Trials,
Non-Clinical Trials, Stability, and
Efficacy Testing.
Project MB4
Page 99 of 112 Pages
UNCLASSIFIED
Exhibit R-3 (PE 0603884BP)
UNCLASSIFIED
DATE
CBDP PROJECT COST ANALYSIS (R-3 Exhibit)
BUDGET ACTIVITY
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
III. Test and Evaluation - Cont.
VACCINES
DTE S - Vaccine Development Includes Phase I/II Clinical and
Non-clinical Trials, Tox Studies,
Surrogate, and Assay Testing
OTHT SB - Vaccine Development
- Includes Stability, and Efficacy
Testing
February 2002
Contract
Method &
Type
Performing Activity &
Location
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
US
NF
CC
Total
PYs
Cost
FY2001
Cost
FY2001
Award
Date
FY2002
Cost
FY2002
Award
Date
FY2003
Cost
FY2003
Award
Date
MB4
Cost to
Complete
Total
Cost
Target
Value of
Contract
C/CPAF DynPort Vaccine
Company, Frederick,
MD
C
6836
10977
Nov-00
12943
Nov-01
0
NONE
0
30756
0
C/CPAF DynPort Vaccine
Company, Frederick,
MD
C
1107
1439
Nov-00
2278
Nov-01
0
NONE
0
4824
0
7943
12416
0
50026
Subtotal III. Test and Evaluation:
15221
14446
Remarks: Cost to Complete: "Continuing"
Project MB4
Page 100 of 112 Pages
UNCLASSIFIED
Exhibit R-3 (PE 0603884BP)
UNCLASSIFIED
DATE
CBDP PROJECT COST ANALYSIS (R-3 Exhibit)
BUDGET ACTIVITY
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
IV. Management Services
VAC BOT
ES C - Support of LR
February 2002
Contract
Method &
Type
Performing Activity &
Location
C/CPAF DynPort Vaccine
Company, Frederick,
MD
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
US
NF
CC
Total
PYs
Cost
FY2001
Cost
FY2001
Award
Date
FY2002
Cost
FY2002
Award
Date
FY2003
Cost
FY2003
Award
Date
MB4
Cost to
Complete
Total
Cost
Target
Value of
Contract
C
0
0
NONE
0
NONE
1474
Nov-02
0
1474
0
PM/MS S - Vaccine Development
- Joint Vaccine Acquisition
Program Management Office
Allot
JVAP, Fort Detrick, MD
U
0
0
NONE
0
NONE
490
Oct-02
0
490
0
PM/MS S - Vaccine Development
- Program Management/Program
Manager Support
Allot
PEOCBD, Falls Church,
VA
U
0
0
NONE
0
NONE
879
Oct-02
0
879
0
PM/MS S - Contractor Systems
Engineering/Program Management
Support.
C/CPFF Camber Corporation,
Frederick, MD
C
0
0
NONE
0
NONE
250
Feb-03
0
250
0
PM/MS S - Contractor Systems
Engineering/Program Management
Support.
C/CPFF SAIC, Frederick, MD
C
0
0
NONE
0
NONE
164
Feb-02
0
164
0
PM/MS S - Award Fee (Maximum
12.5%)
C/CPAF DynPort Vaccine
Company, Frederick,
MD
C
0
0
NONE
0
NONE
1137
Jan-03
0
1137
0
C/CPAF DynPort Vaccine
Company, Frederick,
MD
C
0
0
NONE
0
NONE
1173
Nov-02
0
1173
0
VAC ENC
PM/MS S - Vaccine Development
- Program Management/Program
Manager.
Project MB4
Page 101 of 112 Pages
UNCLASSIFIED
Exhibit R-3 (PE 0603884BP)
UNCLASSIFIED
DATE
CBDP PROJECT COST ANALYSIS (R-3 Exhibit)
BUDGET ACTIVITY
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
IV. Management Services - Cont.
February 2002
Contract
Method &
Type
Performing Activity &
Location
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
US
NF
CC
Total
PYs
Cost
FY2001
Cost
FY2001
Award
Date
FY2002
Cost
FY2002
Award
Date
FY2003
Cost
FY2003
Award
Date
MB4
Cost to
Complete
Total
Cost
Target
Value of
Contract
PM/MS S - Vaccine Development
- Joint Vaccine Acquisition
Program Management Office
Allot
JVAP, Fort Detrick, MD
U
0
0
NONE
0
NONE
389
Oct-02
0
389
0
SBIR/STTR - Aggregated from
ZSBIR-SBIR/STTR
Allot
Joint Program Office for
Biological Defense, Falls
Church, VA
U
0
0
NONE
0
NONE
725
Oct-02
0
725
0
PM/MS S - Contractor Systems
Engineering/Program Management
Support.
C/CPFF Camber Corporation,
Frederick, MD
C
0
0
NONE
0
NONE
199
Feb-03
0
199
0
PM/MS S - Contractor Systems
Engineering/Program Management
Support.
C/CPFF SAIC, Frederick, MD
C
0
0
NONE
0
NONE
130
Feb-03
0
130
0
PM/MS S - Award Fee (12.5%)
C/CPAF DynPort Vaccine
Company, Frederick,
MD
C
0
0
NONE
0
NONE
905
Jan-03
0
905
0
C/CPAF DynPort Vaccine
Company, Frederick,
MD
C
0
0
NONE
0
NONE
200
Jan-03
0
200
0
C/CPAF DynPort Vaccine
Company, Frederick,
MD
C
0
0
NONE
0
NONE
915
Nov-02
0
915
0
VAC NGA
PM/MS S - Award Fee (12.5%)
VAC PLG
PM/MS S - Vaccine Development
- Program Management/Program
Manager Support.
Project MB4
Page 102 of 112 Pages
UNCLASSIFIED
Exhibit R-3 (PE 0603884BP)
UNCLASSIFIED
DATE
CBDP PROJECT COST ANALYSIS (R-3 Exhibit)
BUDGET ACTIVITY
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
IV. Management Services - Cont.
February 2002
Contract
Method &
Type
Performing Activity &
Location
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
US
NF
CC
Total
PYs
Cost
FY2001
Cost
FY2001
Award
Date
FY2002
Cost
FY2002
Award
Date
FY2003
Cost
FY2003
Award
Date
MB4
Cost to
Complete
Total
Cost
Target
Value of
Contract
PM/MS S - Vaccine Development
- Program Management/Program
Manager Support.
Allot
Joint Program Office for
Biological Defense, Falls
Church, VA
U
0
0
NONE
0
NONE
564
Oct-02
0
564
0
PM/MS S - Vaccine Development
- Joint Vaccine Acquisition
Program Management Office
Allot
JVAP, Frederick, MD
U
0
0
NONE
0
NONE
304
Oct-02
0
304
0
PM/MS S - Contractor Systems
Engineering/Program Management
Support.
C/CPFF Camber Corporation,
Frederick, MD
C
0
0
NONE
0
NONE
155
Feb-03
0
155
0
PM/MS S - Contractor Systems
Engineering/Program Management
Support.
C/CPFF SAIC, Frederick, MD
C
0
0
NONE
0
NONE
102
Feb-03
0
102
0
PM/MS S - Award Fee (12.5%)
C/CPAF DynPort Vaccine
Company, Frederick,
MD
C
0
0
NONE
0
NONE
706
Jan-03
0
706
0
C/CPAF DynPort Vaccine
Company, Frederick,
MD
C
0
0
NONE
0
NONE
1161
Nov-02
0
1161
0
U
0
0
NONE
0
NONE
385
Oct-02
0
385
0
VAC TUL
PM/MS S - Vaccine Development
- Program Management/Program
Manager Costs.
PM/MS S - Vaccine Development
- Joint Vaccine Acquisition
Program Management Office
Project MB4
Allot
JVAP, Frederick, MD
Page 103 of 112 Pages
UNCLASSIFIED
Exhibit R-3 (PE 0603884BP)
UNCLASSIFIED
DATE
CBDP PROJECT COST ANALYSIS (R-3 Exhibit)
BUDGET ACTIVITY
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
IV. Management Services - Cont.
PM/MS S - Vaccine Development
- Program Management/Program
Manager Support
February 2002
Contract
Method &
Type
Allot
Performing Activity &
Location
Joint Program Office for
Biological Defense, Falls
Church, VA
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
US
NF
CC
Total
PYs
Cost
FY2001
Cost
FY2001
Award
Date
FY2002
Cost
FY2002
Award
Date
FY2003
Cost
FY2003
Award
Date
MB4
Cost to
Complete
Total
Cost
Target
Value of
Contract
U
0
0
NONE
0
NONE
717
Oct-02
0
717
0
PM/MS S - Contractor Systems
Engineering/Program Management
Support.
C/CPFF Camber Corporation,
Frederick, MD
C
0
0
NONE
0
NONE
197
Feb-03
0
197
0
PM/MS S - Contractor Systems
Engineering/Program Management
Support.
C/CPFF SAIC, Frederick, MD
C
0
0
NONE
0
NONE
129
Feb-03
0
129
0
PM/MS S - Award Fee (12.5%)
C/CPAF DynPort Vaccine
Company, Frederick,
MD
C
0
0
NONE
0
NONE
895
Jan-03
0
895
0
Various
Joint Program Office for
Biological Defense, Falls
Church, VA
U
1931
2127
Oct-00
2022
Oct-01
0
NONE
0
6080
0
HQ AMC, Alexandria,
VA
U
0
0
NONE
0
NONE
0
581
0
1931
2127
0
21006
VACCINES
PM/MS S - Program
management/program manager
support.
ZSBIR
SBIR/STTR - Aggregated from
ZSBIR-SBIR/STTR
PO
Subtotal IV. Management
Services:
581 2Q FY02
2603
14345
Remarks: Cost to Complete: "Continuing"
Project MB4
Page 104 of 112 Pages
UNCLASSIFIED
Exhibit R-3 (PE 0603884BP)
UNCLASSIFIED
CBDP PROJECT COST ANALYSIS (R-3 Exhibit)
BUDGET ACTIVITY
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
TOTAL PROJECT COST:
Project MB4
DATE
February 2002
PE NUMBER AND TITLE
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
18099
28465
Page 105 of 112 Pages
UNCLASSIFIED
34343
42617
MB4
0
123524
Exhibit R-3 (PE 0603884BP)
UNCLASSIFIED
DATE
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2A Exhibit)
BUDGET ACTIVITY
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
COST (In Thousands)
MC4
February 2002
MEDICAL CHEMICAL DEFENSE (DEMVAL)
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
MC4
FY 2001
FY 2002
FY 2003
FY 2004
FY 2005
FY 2006
FY 2007
Cost to
Actual
Estimate
Estimate
Estimate
Estimate
Estimate
Estimate
Complete
2078
1876
1764
1754
1705
2064
Total Cost
2107 Continuing Continuing
A. Mission Description and Budget Item Justification:
Project MC4 MEDICAL CHEMICAL DEFENSE (DEMVAL): This project funds System Development and Demonstration (SDD) of
countermeasures for chemical agents including life support equipment, diagnostic equipment, pretreatment and therapeutic drugs, and
individual/casualty decontamination compounds. A system of medical defense against chemical agents is required to provide protection, to
sustain performance in a chemical environment, and to provide for self-aid and medical treatment of chemical casualties. Fielding of pretreatment
and therapeutic drugs requires Food and Drug Administration (FDA) approval. Multiple long-term studies are required to obtain FDA approval
resulting in longer program timelines and greater program cost than other non-pharmaceutical product programs. Efficacy testing of most
candidate drugs against Chemical Warfare (CW) agents cannot be conducted in humans; therefore, animal surrogate models must be developed.
FY 2001 Accomplishments:
327 Pyridostigmine Bromide - Completed clinical bioequivalence study.
·
·
·
·
·
Project MC4
950 Pyridostigmine Bromide - Initiated program in surrogate species to validate markers of efficacy.
519 Pyridostigmine Bromide - Initiated clinical program in humans to validate markers of efficacy.
99 Advanced Anticonvulsant - Conducted a Subject Matter Expert program review.
88 Advanced Anticonvulsant - Initiated a study to compare midazelam to FDA approved seizure drugs for nerve agent
induced seizures.
Page 106 of 112 Pages
UNCLASSIFIED
Exhibit R-2 (PE 0603884BP)
UNCLASSIFIED
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2A Exhibit)
BUDGET ACTIVITY
DATE
February 2002
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
MC4
FY 2001 Accomplishments (Cont):
95 Advanced Anticonvulsant - Conducted a review on the three leading anticonvulsant candidates for potential serious side
effects.
·
Total
2078
FY 2002 Planned Program:
303 Pyridostigmine Bromide - Continue clinical protocol to validate markers of efficacy.
·
·
·
1064 Advanced Anticonvulsant - Complete 2-year study in surrogate species to validate markers of efficacy.
419 Advanced Anticonvulsant - Start the development of the manufacturing processes, material requirements, formulation,
and packaging for the advanced anticonvulsant to be used in clinical studies.
·
58 Advanced Anticonvulsant - Complete a study to compare midazelam to FDA approved seizure drugs for nerve agent
induced seizures.
·
32 SBIR - Small Business Innovative Research.
Total
Project MC4
1876
Page 107 of 112 Pages
UNCLASSIFIED
Exhibit R-2 (PE 0603884BP)
UNCLASSIFIED
DATE
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2A Exhibit)
BUDGET ACTIVITY
February 2002
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
MC4
FY 2003 Planned Program:
213 Pyridostigmine Bromide - Complete clinical protocol to validate markers of efficacy.
·
·
·
·
·
·
·
·
·
Total
468 Advanced Anticonvulsant - Prepare and submit documentation for Investigational New Drug application.
383 Advanced Anticonvulsant - Continue the development of the manufacturing processes, material requirements,
formulation, and packaging for the advanced anticonvulsant to be used in clinical studies.
50 Advanced Anticonvulsant - Prepare documentation for and conduct Milestone II in-process review.
50 Advanced Anticonvulsant - Complete evaluation of FDA approved seizure drugs for nerve agent induced seizures.
50 Active Topical Skin Protectant (active TSP) - Prepare documentation for and conduct a Milestone Decision Review.
292 Active TSP - Conduct a safety evaluation study in animals.
50 Nerve Agent Scavenger - Prepare documentation for and conduct a Milestone Decision Review.
208 Nerve Agent Scavenger - Formulate for a pre-clinical toxicity study.
1764
B. Other Program Funding Summary:
MC5 MEDICAL CHEMICAL DEFENSE (EMD)
Project MC4
FY 2001
FY 2002
FY 2003
FY 2004
FY 2005
FY 2006
FY 2007
To
Compl
Total
Cost
1050
1463
1973
1486
1448
1727
1763
Cont
Cont
Page 108 of 112 Pages
UNCLASSIFIED
Exhibit R-2 (PE 0603884BP)
UNCLASSIFIED
DATE
CBDP BUDGET ITEM JUSTIFICATION SHEET (R-2A Exhibit)
BUDGET ACTIVITY
February 2002
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
MC4
C. Acquisition Strategy:
Pyrido Bromide
In-house/contractor development to FDA licensure, followed by sole source procurement.
Adv Anticonvuls
In-house/contractor development to FDA licensure, followed by sole source procurement.
D. Schedule Profile:
FY 2000
1
2
3
4
FY 2001
1
2
3
4
FY 2002
1
2
3
4
FY 2003
1
2
3
4
FY 2004
1
2
3
4
FY 2005
1
2
3
4
FY 2006
1
2
3
4
FY 2007
1
2
3
MEDCHEM
Advanced Anticonvulsant - Milestone I
4Q
Advanced Anticonvulsant - Milestone II
3Q
Active TSP - Milestone A
1Q
Nerve Agent Scavenger - Milestone A
Advanced Anticonvulsant - Conduct
studies and reviews
2Q
1Q
4Q
Active TSP - Conduct safety studies
2Q
Nerve Agent Scavenger - Conduct
pre-clinical toxicity study
Project MC4
1Q
Page 109 of 112 Pages
UNCLASSIFIED
4Q
3Q
Exhibit R-2 (PE 0603884BP)
4
UNCLASSIFIED
DATE
CBDP PROJECT COST ANALYSIS (R-3 Exhibit)
BUDGET ACTIVITY
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
I. Product Development
MEDCHEM
HW S - Formulate Advanced
Anticonvulsant in Autoinjector
HW S - FDA Documentation for
Advanced Anticonvulsant
HW S - Milestone II IPR for
Advanced Anticonvulsant
February 2002
Contract
Method &
Type
Performing Activity &
Location
C/CPFF TBS
Allot
USAMMDA, Ft Detrick,
MD
C/CPFF Cambridge Consulting
Corp, Reston, VA
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
US
NF
CC
Total
PYs
Cost
FY2001
Cost
FY2001
Award
Date
FY2002
Cost
FY2002
Award
Date
C
0
0
NONE
429 1Q FY02
U
0
0
NONE
0
C
0
0
NONE
FY2003
Cost
FY2003
Award
Date
MC4
Cost to
Complete
Total
Cost
Target
Value of
Contract
381 1Q FY03
0
810
0
NONE
467 1Q FY03
0
467
0
0
NONE
50 1Q FY03
0
50
0
SW SB - Formulate Nerve Agent
Scavenger for Pre-clinical Study
PO
TBS
C
0
0
NONE
0
NONE
209 1Q FY03
0
209
0
HW S - Milestone I IPR for Active
TSP
PO
Cambridge Consulting
Corp, Reston, VA
C
0
0
NONE
0
NONE
50 1Q FY03
0
50
0
HW S - Milestone I IPR for Nerve
Agent Scavenger
PO
Cambridge Consulting
Corp, Reston, VA
C
0
0
NONE
0
NONE
50 2Q FY03
0
50
0
HW C - Subject Matter Expert
In-Process Review for Advanced
Anticonvulsant
PO
Cambridge Consulting
Corp, Reston, VA
C
0
99 3Q FY01
0
NONE
0
NONE
0
99
0
SW S - Data Search on
Anticonvulsant Candidates Advanced Anticonvulsant
PO
Cambridge Consulting
Corp, Reston, VA
C
0
95 4Q FY01
0
NONE
0
NONE
0
95
0
0
1830
Subtotal I. Product Development:
0
194
429
1207
Remarks:
Project MC4
Page 110 of 112 Pages
UNCLASSIFIED
Exhibit R-3 (PE 0603884BP)
UNCLASSIFIED
DATE
CBDP PROJECT COST ANALYSIS (R-3 Exhibit)
BUDGET ACTIVITY
February 2002
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
MC4
II. Support Costs: Not applicable
III. Test and Evaluation
MEDCHEM
DTE S - Bioequivalence Studies of
Pyridostigmine Bromide
DTE S - Preclinical Efficacy Study
of Advanced Anticonvulsant
Contract
Method &
Type
PO
Allot
Performing Activity &
Location
FY2001
Award
Date
FY2002
Award
Date
USA Medical Research
Institute of Chemical
Defense, APG, MD
U
0
0
NONE
TBS
C
0
0
NONE
DTSL Chemical &
Biological Sciences,
United Kingdom
C
0
950 4Q FY01
C
0
519 4Q FY01
310 1Q FY02
0
88 1Q FY01
59 1Q FY02
SS/FFP
DTE S - Clinical Protocol of
Effects of Pyridostigmine on
Excised Muscle
C/CPAF University of California,
Davis, CA
USA Medical Research
Institute of Chemical
Defense, APG, MD
412
327 1Q FY01
FY2002
Cost
412
DTE S - Ex Vivo Rhesus Muscle
Study for Pyridostigmine Bromide
Subtotal III. Test and Evaluation:
FY2001
Cost
C
PO
Allot
Total
PYs
Cost
TBS
DTE S - Safety Evaluation Study
of Active TSP in Animals
DTE S - Advanced Anticonvulsant
- Evaluate FDA Approved Seizure
Drugs
US
NF
CC
1884
0
NONE
1046 1Q FY02
0
NONE
0
NONE
1415
FY2003
Cost
FY2003
Award
Date
Cost to
Complete
Total
Cost
Target
Value of
Contract
0
NONE
0
739
370
0
NONE
0
1046
0
0
293
0
0
950
0
214 1Q FY03
0
1043
0
50 1Q FY03
0
197
0
0
4268
293 1Q FY03
0
557
NONE
Remarks:
Project MC4
Page 111 of 112 Pages
UNCLASSIFIED
Exhibit R-3 (PE 0603884BP)
UNCLASSIFIED
DATE
CBDP PROJECT COST ANALYSIS (R-3 Exhibit)
BUDGET ACTIVITY
PE NUMBER AND TITLE
RDT&E DEFENSE-WIDE/
BA4 - Demonstration and Validation
IV. Management Services
ZSBIR
SBIR/STTR - Aggregated from
ZSBIR-SBIR/STTR
Subtotal IV. Management
Services:
February 2002
Contract
Method &
Type
PO
Performing Activity &
Location
HQ AMC, Alexandria,
VA
PROJECT
0603884BP CHEMICAL/BIOLOGICAL DEFENSE
(DEMVAL)
US
NF
CC
U
Total
PYs
Cost
FY2001
Cost
FY2001
Award
Date
0
0
0
412
NONE
FY2002
Cost
FY2002
Award
Date
FY2003
Cost
FY2003
Award
Date
32 2Q FY02
0
0
32
2078
1876
NONE
MC4
Cost to
Complete
Total
Cost
Target
Value of
Contract
0
32
0
0
32
1764
0
6130
Remarks:
TOTAL PROJECT COST:
Project MC4
Page 112 of 112 Pages
UNCLASSIFIED
Exhibit R-3 (PE 0603884BP)
0